CN108456668A - A kind of ribosome bind site, recombinant expression plasmid, transformant and its application - Google Patents

A kind of ribosome bind site, recombinant expression plasmid, transformant and its application Download PDF

Info

Publication number
CN108456668A
CN108456668A CN201710091152.0A CN201710091152A CN108456668A CN 108456668 A CN108456668 A CN 108456668A CN 201710091152 A CN201710091152 A CN 201710091152A CN 108456668 A CN108456668 A CN 108456668A
Authority
CN
China
Prior art keywords
leu
ala
gly
val
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710091152.0A
Other languages
Chinese (zh)
Other versions
CN108456668B (en
Inventor
陈玲
周豪宏
刘修才
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cathay R&D Center Co Ltd
CIBT America Inc
Original Assignee
Shanghai Cathay Biotechnology Research and Development Center Co Ltd
Cathay Industrial Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Cathay Biotechnology Research and Development Center Co Ltd, Cathay Industrial Biotech Ltd filed Critical Shanghai Cathay Biotechnology Research and Development Center Co Ltd
Priority to CN201710091152.0A priority Critical patent/CN108456668B/en
Publication of CN108456668A publication Critical patent/CN108456668A/en
Application granted granted Critical
Publication of CN108456668B publication Critical patent/CN108456668B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01018Lysine decarboxylase (4.1.1.18)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

First aspect present invention is related to a kind of ribosome bind site, second aspect is related to including the recombinant expression plasmid of this ribosome bind site, the third aspect is related to including the transformant of the recombinant expression plasmid, the invention further relates to this transformants in fermenting and producing polypeptide, and the further application of the aspect of 1,5 pentanediamine of fermenting and producing.The invention is characterized in that the sequence 5 ' 3 ' of ribosome bind site includes one of sequence as follows:a)、GTCATCAAAA;b)、CGCAAAGATA;c)、AAAGATTTAC.The present invention can reduce the toxic action that 1,5 pentanediamines utilize microbial cell glucose production L lysines during one-step method is using 1,5 pentanediamine of glucose production, improve the yield of 1,5 pentanediamines.

Description

A kind of ribosome bind site, recombinant expression plasmid, transformant and its application
Technical field
First aspect present invention is related to a kind of ribosome bind site, and second aspect is related to including this ribosome binding site The recombinant expression plasmid of point, the third aspect are related to including the transformant of the recombinant expression plasmid, and the invention further relates to this turn Beggar is in fermenting and producing polypeptide, and further fermenting and producing 1, the application of the aspect of 5- pentanediamines.
Background technology
Lysine decarboxylase (L-lysine decarboxylase, abbreviation LDC, EC 4.1.1.18) is widely present in micro- Biology, insect, in animal and higher plant, L-lysine can be sloughed a carboxyl generate 1,5- pentanediamines (cadaverine) and CO2.And the purposes of 1,5- pentanediamine is quite extensive, such as polymerisation synthesizing new nylon can be carried out with binary acid, in work There is very high application value in industry production.Currently, microbial method 1, the production of 5- pentanediamines mainly uses following two methods, micro- Biofermentation produces (abbreviation one-step method) and microbial body exoenzyme catalytic production 1,5- pentanediamines (abbreviation two-step method).
105441497 A of Chinese patent CN are (IPTG/ lactose) inducible promoter-signal peptide-by building structure The expression cassette of lysine decarboxylase gene-terminator so that a large amount of secreting, expressings of lysine decarboxylase gene.First by can be with The Escherichia coli of high-yield L-lysine or Corynebacterium glutamicum strain produce L-lysine using glucose fermentation, then pass through addition The derivants inducing lysine decarboxylase secreting, expressing such as IPTG/ lactose, catalysis L-lysine are converted into cadaverine.It may be implemented in this way 1,5- pentanediamines, i.e. microbial fermentation production L-lysine and coupling catalysed L-lysine decarboxylation are produced using glucose by one step Reaction generates 1,5- pentanediamines.(abbreviation one-step method) but the system leak expression other than needing additional addition IPTG/ lactose Situation is also than more serious, since 1, the 5- pentanediamine concentration that thalline itself is resistant to is limited, if fermentation system mid-early stage expresses 1, the 5- pentanediamines that lysine decarboxylase is converted into are excessive, will cause to poison to thalline, to inhibit thalli growth and profit With process (Qian, the et al., Biotechnol.Bioeng.2011 of glucose production L-lysine;108:93–103). During glucose by one step produces 1,5- pentanediamines, if using constitutive promoter, it can effectively save and ferment The cost of the derivant added in journey, but the expression quantity of lysine decarboxylase must be controlled, otherwise earlier fermentation generate 1,5- Pentanediamine can seriously inhibit the growth of thalline so that fermentation process is interrupted.If the table of regulation and control lysine decarboxylase can be attempted The production quantity of 1,5- pentanediamines is reduced up to amount so that 1, the 5- pentanediamines that are converted into thalli growth and will not utilize Portugal The process that grape sugar produces L-lysine generates depression effect, and if things go on like this, thalline also will produce in incubation to 1,5- penta The tolerance of diamines realizes abundant conversion of the last lysine to 1,5- pentanediamines.But it must assure that remaining lysine simultaneously Cannot be too many, otherwise one side lysine can check the activity that relevant enzyme is synthesized in lysine, on the other hand be given birth in one-step method Produce 1,5- pentanediamines after fermentation, it is necessary to additionally add a large amount of lysine decarboxylase again and convert remaining lysine.
Invention content
In order to screen the mutant strain of different lysine decarboxylase expression quantity, the method pair of nonideal explosives may be used The ribosome bind site (RBS) for influencing gene translation level is mutated, in particular by by the gene cloning of zymoprotein Into a suitable expression vector, then purposive design synthesizes one group of random primer and carries out random mutation to RBS sequences, By high flux screening and method for detecting enzymatic activity is combined, to obtain the mutant plasmid with expected phenotype.
The present invention carries out the sites RBS before lysine decarboxylase gene start codon by the means of nonideal explosives Random mutation, and high flux screening wild-type lysine decarboxylase compared with the method for enzyme activity determination obtains one group of activity is combined to go out The mutant strain now reduced after the RBS sequences for identifying mutation, mutant plasmid is converted into Strains for Lysine Production, Neng Gou One-step method utilizes glucose production 1, reduces toxic action of 1, the 5- pentanediamines to microbial cell during 5- pentanediamines, carries The yield of high 1,5- pentanediamines will have important meaning and help to industrial production.
The first aspect of the present invention purpose is to propose a kind of ribosome bind site, can reduce during the fermentation Expression product and (or) toxic action of the subsequent products to microbial cell, such as can one-step method utilize glucose production 1, Toxic action of 1, the 5- pentanediamines to microbial cell is reduced during 5- pentanediamines, improves the yield of 1,5- pentanediamines.
The sequence 5 ' -3 ' of a kind of ribosome bind site, the ribosome bind site includes that (either) is as follows One of sequence:
a)、GTCATCAAAA;
b)、CGCAAAGATA;
c)、AAAGATTTAC。
The second aspect of the present invention purpose is to propose a kind of recombinant expression plasmid, can reduce table during the fermentation Up to product and (or) toxic action of the subsequent products to microbial cell, such as can one-step method utilize glucose production 1,5- Toxic action of 1, the 5- pentanediamines to microbial cell is reduced during pentanediamine, improves the yield of 1,5- pentanediamines.
A kind of recombinant expression plasmid, including the target gene of recombinant expression plasmid and corresponding ribosome bind site, institute Ribosome bind site is stated as described in any technical solution above, it is preferable that the ribosome bind site is located at initiation codon Sub- upstream -15 arrives -6.
Further, a kind of recombinant expression plasmid, skeleton plasmid are the reproducible skeleton matter in host cell Grain, it is excellent when host cell is in Escherichia coli (Escherichia coli) and hafnia alvei (Hafnia alvei) Select one kind in pUC, pBR322, pACYC plasmid and their plasmid.
Based on the above technical solution further, the target gene of the recombinant expression plasmid is to encode gathering for polypeptide Nucleotide;The polypeptide is enzyme or polypeptide drug;Further, the enzyme is oxidoreducing enzyme, transferase, hydrolysis At least one of enzyme, lyase, isomerase and ligase, the polypeptide drug are in hormone, antibody and growth factor It is at least one;Further, the lyase is decarboxylase, and still further, the decarboxylase is amino acid decarboxylases, is such as relied Propylhomoserin decarboxylase, tyrosine decarboxylase, arginine decarboxylase, ornithine decarboxylase or glutamate decarboxylase.Again further, it compiles The polynucleotide of code lysine decarboxylase is can to derive from microorganism, and the cell of animal or plant such as derives from Escherichia coli (Escherichia coli), bacillus subtilis (Bacillus subtilis), Alkaliphilic bacillus (Bacillus Halodurans), streptomyces coelicolor (Streptomyces coelicolor), hafnia alvei (Hafnia alvei), Corynebacterium glutamicum (Corynebacterium glutamicum) or klebsiella oxytoca (Klebsiella Oxytoca lysine decarboxylase gene);The lysine decarboxylase gene can be from above-mentioned bacterial strains by mutagenesis or Bacterial strain after random mutation or genetic engineering bacterium.It is further preferred that the polynucleotide of coding lysine decarboxylase is cadA The segment of gene, ldcC genes, haldc genes, the segment of cadA genes, the segment of ldcC genes or haldc genes;More into one Preferably, the lysine decarboxylase gene is derived from the induction type lysine decarboxylase gene C adA/ of Escherichia coli to step LdcI(SEQ ID No:1).Lysine decarboxylase can also be that the mutant of the lysine decarboxylase in above-mentioned source is (including natural Mutant and artificial recombination mutant) or active fragment.
The third aspect of the present invention purpose is to propose a kind of transformant, can reduce expression product during the fermentation And (or) toxic action of the subsequent products to microbial cell, for example glucose production 1,5- pentanediamines can be utilized in one-step method During reduce 1,5- pentanediamines to microbial cell utilize glucose production L-lysine toxic action, improve 1,5- penta The yield of diamines.
A kind of transformant, the recombinant expression plasmid of the transformant are the recombination tables as described in any one technical solution above Up to plasmid.
Or a kind of transformant, the genome of the transformant include target gene and corresponding ribosome bind site, The ribosome bind site is it is preferable to which ground, the ribosome bind site are located at upstream from start codon -15 To -6;The target gene is the polynucleotide for encoding polypeptide;The polypeptide is enzyme or polypeptide drug;Further preferably Ground, the enzyme are at least one of oxidoreducing enzyme, transferase, hydrolase, lyase, isomerase and ligase, described Polypeptide drug is at least one of hormone, antibody and growth factor;Further preferably, the lyase is decarboxylation Enzyme, it is further preferred that the decarboxylase is amino acid decarboxylases, such as lysine decarboxylase, tyrosine decarboxylase, arginine Decarboxylase, ornithine decarboxylase or glutamate decarboxylase.
Further, the target gene of the recombinant expression plasmid of the transformant is the poly-nuclear glycosides for encoding lysine decarboxylase Acid, further, the polynucleotide of the coding lysine decarboxylase are derived from Escherichia coli (E.coli), bacillus subtilis Bacterium (B.subtilis), Alkaliphilic bacillus (B.halodurans), streptomyces coelicolor (S.coelicolor), honeycomb Hough Buddhist nun bacterium (H.alvei), corynebacterium glutamicum (C.glutamicum) or klebsiella oxytoca (K.oxytoca) rely Propylhomoserin decarboxylase gene;Further, the polynucleotide for encoding lysine decarboxylase is cadA genes, ldcC genes, haldc bases Cause, the segment of the segment of cadA genes, the segment of ldcC genes or haldc genes;Still further, the cadA genes come Derived from the cadA genes of Escherichia coli (E.coli).
On the basis of any of the above-described technical solution further, the host strain of the transformant is Escherichia coli (E.coli), bacillus subtilis (B.subtilis), streptomyces coelicolor (S.coelicolor), hafnia alvei (H.alvei) or corynebacterium glutamicum (C.glutamicum), it is further preferred that Escherichia coli (E.coli) or honeycomb breathe out Husband Buddhist nun bacterium (H.alvei).
The fourth aspect of the present invention purpose is to propose a kind of method of fermenting and producing polypeptide, during the fermentation can Reduce expression product and (or) toxic action of the subsequent products to microbial cell, such as can one-step method using glucose life 1,5- pentanediamines are reduced during producing 1,5- pentanediamines to make microbial cell using the murder by poisoning of glucose production L-lysine With the yield of raising 1,5- pentanediamines.
A kind of method of fermenting and producing polypeptide, includes the following steps:
A) transformant of the culture as described in any technical solution above;
B) polypeptide is obtained from the bacterium solution or thalline obtained in step A.
Further, the method for a kind of fermenting and producing polypeptide, is the method for fermenting and producing lysine decarboxylase, including Following steps:
1) transformant of the culture as described in any technical solution above, the purpose base of the recombinant expression plasmid of the transformant Because being the polynucleotide for encoding lysine decarboxylase;
2) lysine decarboxylase is obtained in the bacterium solution or thalline that are obtained from step 1.
The fifth aspect of the present invention purpose is to propose a kind of fermenting and producing 1, the method for 5- pentanediamines, in fermentation process In can reduce expression product and (or) toxic action of the subsequent products to microbial cell, such as can one-step method utilize Portugal Grape sugar reduces 1,5- pentanediamines and utilizes glucose production L-lysine to microbial cell during producing 1,5- pentanediamines Toxic action improves the yield of 1,5- pentanediamines.
A kind of fermenting and producing 1, the method for 5- pentanediamines include the following steps:
The culture transformant that can produce lysine decarboxylase as described above, the host strain of the transformant can also Lysine is produced, the lysine decarboxylase catalysis lysine decarboxylation generates 1,5- pentanediamines.
The sixth aspect of the present invention purpose is to propose a kind of mRNA, with can reduce during the fermentation expression product and (or) toxic action of the subsequent products to microbial cell, for example glucose production 1 can be utilized in one-step method, 5- pentanediamines The toxic action that 1,5- pentanediamines utilize microbial cell glucose production L-lysine is reduced in the process, improves 1,5- penta 2 The yield of amine.
A kind of mRNA, which is characterized in that the sequence of the mRNA includes and ribosome bind site described in claim 1 Corresponding sequence.
Beneficial effects of the present invention:
The present invention is based on the methods of nonideal explosives, and in conjunction with the method for random mutation and high flux screening, later use relies Propylhomoserin conversion ratio and the detection of lysine decarboxylase expression can obtain a series of capable of regulating and controlling lysine decarboxylase difference table Up to the ribosome bind site of intensity, the recombination lysine decarboxylase expression plasmid of these ribosome bind sites is carried, and Obtain a series of mutant strain of lysine decarboxylase difference expressions.Wherein lysine decarboxylase expression declines (this Invention at least declines mutant strain 25%), and lysine decarboxylase recombinant expression plasmid contained therein can be used for subsequently turning Change into Strains for Lysine Production, recombinant bacterial strain can have early period in the process for producing 1,5- pentanediamines using glucose by one step The guarantee of effect generates 1, the 5- pentanediamines of relatively low amount, therefore reduces 1,5- pentanediamines in earlier fermentation and utilize glucose fungus to thalline The toxic effect of body growth maintains production lysine and produces the balance between 1,5- pentanediamines, and last resultant effect can improve The yield of 1, the 5- pentanediamines of Strains for Lysine Production One-step production, while ensureing that remaining lysine is few as possible.The present invention The mutant strain that declines of lysine decarboxylase expression, the substantially binding ability in the sites RBS of ribosomes and mRNA Decline.The present invention can be used not only for reducing the expression quantity of lysine decarboxylase, can be also used for the expression for reducing other polypeptides Amount.
Description of the drawings
Fig. 1 is that (lysine is de- for the SDS-PAGE analyses of wild type and the mutant strain lysine decarboxylase CadA of same OD Carboxylic acid monomer molecule amount about 80kDa);
Fig. 2 is suppression curve of the various concentration pentanediamine to thalli growth.
Specific implementation mode
Below in conjunction with the accompanying drawings, the present invention will be described in detail.
It uses in the present invention and such as gives a definition:
1. the base sequence used in the present invention, the abbreviation of nucleotide, amino acid (single-letter) are to be based on international theory With applied chemistry federation and international bio federation to the regulation of biological chemical name, European Journal are can refer to The " of the phase of volume 138 the 9th end of the year 1984 of of Biochemistry prepares the finger of the specification containing base sequence and amino acid sequence Lead the abbreviation in mono- texts of ", and general abbreviation in biotechnology.
2.RBS sequence representation methods:
Unless otherwise specified, RBS sequences are 5 ' -3 ' expressions, and the sequence that the identification provided in this specification obtains (is shown in Table 2) base before being ATG, wherein RBS are pointed out with black matrix underscore.
The first aspect of the present invention proposes a kind of ribosome bind site, the ribosome bind site, the ribosomes The sequence 5 ' -3 ' of binding site includes one of sequence as follows:
a)、GTCATCAAAA;
b)、CGCAAAGATA;
c)、AAAGATTTAC。
The second aspect of the present invention purpose is to propose a kind of recombinant expression plasmid, the recombinant expression plasmid, including recombination The target gene of expression plasmid and corresponding ribosome bind site, the ribosome bind site any technical solution such as above It is described, it is preferable that the ribosome bind site is located at upstream from start codon -15 and arrives -6.A kind of recombinant expression Plasmid, skeleton plasmid are the reproducible skeleton plasmids in host cell, when host cell is Escherichia coli and Hough Buddhist nun bacterium When middle, preferably pUC, pBR322, pACYC plasmid (being purchased from precious bioengineering (Dalian) Co., Ltd) and their plasmid In one kind.PUC plasmids preferably such as pUC18 and pUC19 plasmids.The target gene of the recombinant expression plasmid is coding polypeptide Polynucleotide;The polypeptide is enzyme or polypeptide drug;Further, the enzyme is oxidoreducing enzyme, transferase, water At least one of enzyme, lyase, isomerase and ligase are solved, the polypeptide drug is in hormone, antibody and growth factor At least one;Further, the lyase is decarboxylase, and still further, the decarboxylase is amino acid decarboxylases, such as Lysine decarboxylase, tyrosine decarboxylase, arginine decarboxylase, ornithine decarboxylase or glutamate decarboxylase.Again further, The polynucleotide for encoding lysine decarboxylase is to can come from microorganism, the cell of animal or plant, such as derives from Escherichia coli (E.coli), bacillus subtilis (B.subtilis), Alkaliphilic bacillus (B.halodurans), streptomyces coelicolor (S.coelicolor), hafnia alvei (H.alvei), corynebacterium glutamicum (C.glutamicum) or Oaksey support gram The lysine decarboxylase gene of the white bacillus of thunder (K.oxytoca);The lysine decarboxylase gene can also derive from above-mentioned bacterium Bacterial strain or genetic engineering bacterium of the strain after mutagenesis or random mutation.It is further preferred that coding lysine decarboxylase is poly- Nucleotide is cadA genes, ldcC genes, haldc genes, the segment of cadA genes, the segment of ldcC genes or haldc genes Segment;It is further preferred that the lysine decarboxylase gene is derived from the induction type lysine decarboxylation of Escherichia coli Enzyme gene CadA/LdcI (SEQ ID No:1).Lysine decarboxylase can also be the mutation of the lysine decarboxylase in above-mentioned source Body (including natural mutation and artificial recombination mutant) or active fragment.
The third aspect of the present invention proposes a kind of transformant, and the recombinant expression plasmid of the transformant is as any one of above Recombinant expression plasmid described in technical solution;Or the genome of the transformant includes target gene and corresponding ribosomes knot Site is closed, the ribosome bind site is it is preferable to which ground, the ribosome bind site are located in initiation codon Trip -15 to -6;The target gene of target gene recombinant expression plasmid as described above.Preferably, the transformant Recombinant expression plasmid target gene be encode lysine decarboxylase polynucleotide, encode the poly-nuclear glycosides of lysine decarboxylase Acid is derived from Escherichia coli (Escherichia coli), bacillus subtilis (Bacillus subtilis), basophilic gemma Bacillus (Bacillus halodurans), streptomyces coelicolor (Streptomyces coelicolor), hafnia alvei (Hafnia alvei), corynebacterium glutamicum (Corynebacterium glutamicum) or klebsiella oxytoca The lysine decarboxylase gene of (Klebsiella oxytoca);Further, encoding the polynucleotide of lysine decarboxylase is The segment of cadA genes, ldcC genes, haldc genes, the segment of cadA genes, the segment of ldcC genes or haldc genes;More Further, the cadA genes are derived from the cadA genes of Escherichia coli (E.coli).
The host strain of the transformant is Escherichia coli (E.coli), bacillus subtilis (B.subtilis), sky blue Streptomycete (S.coelicolor), hafnia alvei (H.alvei) or corynebacterium glutamicum (C.glutamicum), into one Step is preferably Escherichia coli (E.coli) or hafnia alvei (H.alvei).
The fourth aspect of the present invention has been a kind of method of fermenting and producing polypeptide of proposition, the side of the fermenting and producing polypeptide Method includes the following steps:
A) transformant of the culture as described in any technical solution above, the purpose base of the recombinant expression plasmid of the transformant Because being the polynucleotide for encoding lysine decarboxylase;
B) from step A) in obtained bacterium solution or obtain polypeptide in thalline.
Further, the method for a kind of fermenting and producing polypeptide, is the method for fermenting and producing lysine decarboxylase, including Following steps:
1) transformant of the culture as described in any technical solution above;
2) lysine decarboxylase is obtained in the bacterium solution or thalline that are obtained from step 1).
The fifth aspect of the present invention proposes a kind of fermenting and producing 1, the method for 5- pentanediamines, the fermenting and producing 1,5- penta 2 The method of amine, includes the following steps:
The culture transformant that can produce lysine decarboxylase as described above, the host strain of the transformant can also Lysine is produced, the lysine decarboxylase is catalyzed the lysine decarboxylation and generates 1,5- pentanediamines.
It is an object of the invention to the sides by carrying out random mutation to lysine decarboxylase ribosome bind site (RBS) Method builds a series of lysine decarboxylase expression vector of different translation skills, in conjunction with the means of high flux screening and enzyme activity determination Identify one group of RBS that can regulate and control lysine decarboxylase translation.By the lysine decarboxylase expression containing these mutational sites Plasmid is transformed into hafnia alvei strain, can obtain a series of recombinant bacterial strain of different lysine decarboxylase expressions; Lysine decarboxylase expression plasmid containing these mutational sites is transformed into Strains for Lysine Production, grape can utilized A series of recombinant bacterial strain of difference 1,5- pentanediamine yield is obtained when sugar fermentation.
The present invention is first with Escherichia coli (E.coli MG1655K12, purchased from Beijing day bounties Gene Tech. Company Limited) Genome is that template clones lysine decarboxylase CadA encoding genes, and is building up in suitable expression vector, makes it Can in E. coli BL21 or hafnia alvei (H.alvei) successful expression.And then using synthesis with power traction The object and method expanded to plasmid is mutated the RBS sequences at its 5 ' end, and pass through the method for high flux screening and obtain The mutant strain that one group of lysine decarboxylase lysine conversion ratio is raised and lowered.Pass through the RBS of the method identification mutation of sequencing Sequence.These mutant plasmids are further converted into hafnia alvei strain verification since the RBS mutation on plasmid cause Lysine decarboxylase expression change situation;Lysine decarboxylase expression intensity subtracts caused by being mutated again due to RBS Weak plasmid is converted into Strains for Lysine Production, and one-step fermentation is carried out using recombination Strains for Lysine Production, can be notable Improve the yield of the 1,5- pentanediamines of its production.
In some embodiments, for screening since RBS mutation cause the lysine decarboxylase of different expression intensities prominent Selected host cell can be microorganism, plant or zooblast, preferred microorganism cell when variant.In some embodiment party In case, for screening since RBS mutation cause to be selected as host's when the lysine decarboxylase mutant of different expression intensities Microorganism can be Escherichia coli (E.coli), bacillus subtilis (B.subtilis), streptomyces coelicolor (S.coelicolor), hafnia alvei (H.alvei) or corynebacterium glutamicum (C.glutamicum), preferably large intestine bar Bacterium BL21 (E.coli BL21 (DE3)).
In some embodiments, for verifying since RBS mutation lead to the prominent of different lysine decarboxylase expression intensities The host cell for becoming selected when plasmid can be microorganism, plant or zooblast, preferred microorganism cell.In some implementations In scheme, for verifying since RBS mutation cause to be selected as place when the mutant plasmid of different lysine decarboxylase expression intensities Main microorganism can be Escherichia coli (E.coli), bacillus subtilis (B.subtilis), streptomyces coelicolor (S.coelicolor), hafnia alvei (H.alvei) or corynebacterium glutamicum (C.glutamicum), preferably honeycomb breathe out Husband Buddhist nun bacterium (H.alvei).
In some case study on implementation, Strains for Lysine Production is that can produce lysine after being transformed by genetic engineering means Bacterial strain, host strain is Escherichia coli, which is industrial strain suitable for commercial scale.Industrial bacterium Strain can be cultivated in amplification test, including be cultivated in shaking flask and fermentation tank, and the scale of culture can be sufficiently large.
In some embodiments, the temperature for cultivating thalline can be any temperature that can allow thalli growth, appropriate Temperature be 20~40 degree, preferably 30~40 degree, more preferable 35~40 degree.The time of culture can be about 1 day, about 2 days, about 3 It, about 4 days, about 5 days, about 6 days, about 7 days, about 8 days, about 9 days or about 10 days.
Contain polypeptide, peptone, vitamin, trace element and minerals in the culture medium of some case study on implementation, transformant, Such culture medium may include but be not limited to common LB culture mediums (by tryptone, yeast extract and sodium chloride be molten Xie Yushui is made).
In some embodiments, cell lysine conversion ratio is catalyzed lysine using magnetic nuclear resonance method detection lysine The amounts of the 1,5- pentanediamines being converted into calculates.
The PCR amplification mentioned in following embodiment, comparative example, plasmid extraction, digestion, digestion products connection specific step Suddenly, conditional parameter etc. presses the condition progress of the specification suggestion of purchased relevant enzyme and reagent.DNA wherein used in PCR amplification The ligase used in restriction enzyme, digestion products connection used in polymerase, digestion is purchased from precious bioengineering (Dalian) Co., Ltd;Plasmid extraction kit, DNA plastic recovery kits, PCR purification kits are purchased from healthy and free from worry life science (Wujiang) Co., Ltd, trade mark Axygen;Primer is purchased from silent winged scientific and technological (China) Co., Ltd of generation that of match, trade mark INVITROGEN;Have Except illustrating.
Unless otherwise specified, the method for transformation mentioned in following embodiment, comparative example is as follows:By the connection product of 10 μ l or The plasmid of 2 μ l is added into e. coli bl21 (DE3) competent cell of 100 μ l, the heat shock in 42 DEG C after ice bath 20min 90s.The LB culture mediums of 1ml are added after incubation 5min on ice.It is applied in corresponding resistant panel.
OD600(OD562nm) measurement method:The culture medium for not cultivating cell of 3ml is added in the cuvette of 1cm wide, The school light (ABS) is absorbed in UV-8000 ultraviolet-uisible spectrophotometers (Shanghai Yuan Xi Instrument Ltd.) under 600nm (562nm) Zero.Cuvette is cleaned, the culture medium that 2.9ml does not cultivate bacterium is added after drying, is added after the zymotic fluid mixing of 0.1ml in UV- The absorption light value under 600nm (562nm) is tested in 8000 ultraviolet-uisible spectrophotometers.It is to send out that instrument, which shows that numerical value is multiplied by 30, The OD of zymotic fluid600(OD562nm)。
Embodiment 1
1.1, the clone of lysine decarboxylase gene cadA
Using primer cadA--SacI-F and cadA--XbaI-R (primer shown in table 1) by lysine decarboxylase (SEQ ID No:1) encoding gene cadA (SEQ ID No:2) from Escherichia coli MG1655K12 (E.coli MG1655K12, purchased from north Jing Tian bounties Bioisystech Co., Ltd) genome in amplify, after SacI and XbaI double digestions, be connected into same double Connection product is obtained in the pUC18 plasmids (purchased from precious bioengineering (Dalian) Co., Ltd) of digestion.Utilize CaCl2It is prepared by method The competent cell of E.coli BL21 (purchased from precious bioengineering (Dalian) Co., Ltd), is used in combination heat shock method to turn connection product Change into E.coli BL21 cells, is screened using the ammonia benzyl antibiotic for adding 100 μ g/ml in LB culture mediums, clone PCR After sequence verification (verification cadA sequences are correct), extracting plasmid obtains pCIB60 plasmids.
Using plasmid pCIB60 as template, further utilize cadA-F2 and cadA-R2 to cadA genes in pCIB60 plasmids 5 ' sequences optimize (in order to allow CadA smoothly to state, cadA genes 5 ' end upstream sequences by
5’-ATTTCACACAGGAAACAGCTATGACCATGATTACGAATTCGAGCTC- 3 ' replace with
5’-ATTTCACACAGGAAACAGCT-3’).After PCR amplification, using DpnI restriction enzymes to PCR product into Row digestion, converts also with heat shock method into E.coli BL21, sequence verification (5 ' end upstream sequences of verification cadA genes By 5 '-ATTTCACACAGGAAACAGCTATGACCATGATTACGAATTCGAGCTC- 3 ' replace for 5 '- ATTTCACACAGGAAACAGCT-3 ') after obtain plasmid pCIB71.
Used primer in 1. present invention of table.
The structure in RBS random mutations library and its screening before 1.2 lysine decarboxylase gene C adA coded sequences
Using constructed plasmid pCIB71 in 1.1 as template, random primer cadA-RBS-F and cadA-RBS- are utilized R (table 1) is expanded, and introduces mutation in the process.The prior art is (see Schurr T, Nadir E, Margalit H.Identification and characterization of E.coli ribosomal binding sites by free energy computation..Nucleic Acids Research,1993,21(21):4019-4023) prediction is exhausted - 7 Dao -12 before most of gene start codons (ATG) are ribosome bind site (RBS), and the present invention will be -6 to -15 This section of sequence is considered RBS.
PCR system prepares (50 μ l):
25μlMax archaeal dna polymerases (2 × Premix, precious bioengineering (Dalian) Co., Ltd)
1 μ l forward primers cadA-RBS-F (10 μM)
1 μ l reverse primers cadA-RBS-R (10 μM)
1 μ l template DNAs (400ng)
22μl ddH2O to total volume be 50 μ l.
PCR programs:95 DEG C of denaturation 2min;95 DEG C of denaturation 30s, 55 DEG C of annealing 30s, 72 DEG C of extension 2min 30s, 35 are followed Ring;72 DEG C extend eventually, 7min.
After amplification, PCR product is cleaned using Axygen PCR cleanup kits.Restriction enzyme DpnI digestions, after 37 DEG C overnight (16h), digestion products are totally converted to E.coli JM109 (purchased from precious bioengineering (Dalian) Co., Ltd) in, build mutant library.
The plasmid of the recombination lysine decarboxylase mutator in mutant library is extracted, and is converted again to E.coli (while converting in pCIB71 plasmids to E.coli BL21 bacterial strains, obtain bacterial strain CIB71 as a contrast), coating in BL21 bacterial strains Screening primary dcreening operation is carried out in the LB resistant panels containing 100 μ g/ml ampicillins, specifically about 1000 lists of random picking 37 DEG C are cloned in the 96 hole deep-well plates containing liquid LB (+100 μ g/ml ampicillins), and (instrument is purchased from Shanghai generation to 250rpm Flat experimental facilities Co., Ltd, type low capacity total temperature constant temperature culture oscillator free from worldly cares, model SPH-200B) overnight incubation ((16h)).Respectively taken using the volley of rifle fire in the LB culture solutions to a 96 new hole deep-well plates of 600 μ l (while reaction is set and is started not The reacting hole of addition, the after reaction bacterium solution of addition control strain is as blank control), and the lysine salt of 400 μ l is added Acid solution (a concentration of 400g/l) and coenzyme PLP (phosphopyridoxal pyridoxal phosphate, final concentration of 0.1mM), in 37 DEG C, 250rpm (purchase by instrument From Shanghai Shiping Experiment Equipment Co., Ltd., type low capacity total temperature constant temperature culture oscillator free from worldly cares, model SPH-200B) reaction 2hrs, can be with the raising of pH, after reaction in every according to the generation of 1,5- pentanediamines in lysine decarboxylase catalytic process Acid-base indicator (indicator B is added dropwise in a reacting hole:1mg Bromothymol blues are dissolved in 10ml deionized waters;Indicator C: 10mg dimethyl diaminophenazine chlorides are dissolved in 10ml ethyl alcohol;Indicator C and B press 1:1 volume ratio mixes), according to the apparent phase of indicator color picking The mutant strain of raised to the pH of unmutated control strain CIB71 more or few (but opposite blank control still has color change) into Row secondary screening and sequencing identification mutation RBS sequences.
1.3RBS mutant libraries the selection result and mutational site sequencing identification
Primary dcreening operation is carried out to the CadA fallibility PCR mutant libraries of structure, have in 1000 monoclonals 51 in 96 hole deep holes The judgement that can not grown in plate is false positive clones;It is apparent that 15 clone's color changes are screened in remaining 949 clones altogether It is better than the mutant strain of control strain, screens 14 monoclonal color changes significantly lower than unmutated control strain CIB71's Mutant strain.Secondary screening (secondary screening method and primary dcreening operation are same) twice is carried out to this 29 clones.Therefrom it is determined that 3 clones are apparent after secondary screening There is the lysine decarboxylase activity less than control.There are 3 plants of monoclonals to be apparently higher than the lysine decarboxylase activity of control.
This 6 clones are further seeded to 5ml LB liquid mediums (containing 100 μ g/ml ampicillins) to train It supports, 37 DEG C, (instrument is purchased from Shanghai Shiping Experiment Equipment Co., Ltd. to 250rpm, and type low capacity total temperature constant temperature incubation free from worldly cares is shaken Swing device, model SPH-200B) overnight (16h).Sequencing identification is carried out to the sequence before lysine decarboxylase gene after extracting plasmid RBS sequences are mutated, sequencing result is as shown in table 2 below.
Table 2:The 6 plant mutant body mutational sites identification screened in CadA fallibility mutant libraries.
1.4 lysine decarboxylase CadA mutain lysine conversion ratios measure
Plasmid and control pCIB71 plasmids that extracted in 1.3 8 are cloned are converted respectively to honeycomb Hough Buddhist nun (H.alvei) it in competent cell, is coated in the LB resistant panels containing 100 μ g/ml ampicillins and is screened.Into One step distinguishes each 5 monoclonals of picking, is cultivated, 37 using 5ml LB liquid mediums (containing 100 μ g/ml ampicillins) DEG C, 250rpm (instrument be purchased from Shanghai Shiping Experiment Equipment Co., Ltd., type low capacity total temperature constant temperature culture oscillator free from worldly cares, Model SPH-200B) overnight (16h).It takes respectively in the LB culture solutions to EP pipes of 600 μ l respectively cloned, and relying for 400 μ l is added Propylhomoserin hydrochloric acid solution (a concentration of 400g/l) and coenzyme PLP (phosphopyridoxal pyridoxal phosphate, final concentration of 0.1mM), natural pH is (about 6.7), in 37 DEG C, (instrument is purchased from Shanghai Shiping Experiment Equipment Co., Ltd., type low capacity total temperature constant temperature training free from worldly cares to 250rpm Support oscillator, model SPH-200B) reaction 2hrs, after reaction to reaction solution carry out 12000rpm centrifugation 3min (room temperature from Scheming, brand and model Beckman coulter microfuge 16centrifuge, similarly hereinafter), on the reaction solution for taking 500 μ l Clearly in nuclear magnetic tube, and 100 μ l D are added2O:DMSO=30:1 (mass ratio) is used as internal standard, is reacted using magnetic resonance detection The amount of remaining lysine in system (calculates 1,5- penta with the amount of this 1,5- pentanediamine for calculating generation and lysine conversion ratio The mole of diamines divided by remaining lysine and 1, the integral molar quantity of 5- pentanediamines), and then calculate relying relatively for opposite CIB71 Propylhomoserin conversion ratio, the results are shown in Table 3.
3. nuclear-magnetism of table detects lysine conversion ratio and OD of 3 plants of CadA mutant strains compared with wild-type strain600
As shown in table 3, in the identical reaction time, containing mutation RBS plasmids pCIB71-RBS1, pCIB71-RBS2 and The lysine conversion ratio of the mutant strain of pCIB71-RBS3 respectively be compare CIB71 bacterial strains 38%, 58% and 75%, and this three Plant mutant strain grows no significant difference compared with the control.Thus analysis is since RBS mutation cause lysine decarboxylase to express water It is flat to decline, it is converted so as to cause mutant strain CIB71-RBS-1, CIB71-RBS-2 and CIB71-RBS-3 cell effect lysine Rate declines.And this five plant mutants bacterial strain of CIB71-RBS-4, CIB71-RBS5, CIB71-RBS-6 lysine conversion compared with the control Rate is all significantly increased, and is the 189%, 168% and 177% of control respectively;Wherein CIB71-RBS-4, CIB71-RBS-5, The growth of this three plant mutants strain of CIB71-RBS-6 is compared with the control without significant changes, in order to further verify these mutant strain phases It is lysine decarboxylase gene expression amount caused by the simple mutation because of RBS to increasing or decreasing for control lysine conversion ratio Raising, rather than be that the conversion ratio caused by thalli growth velocity variations increases or decreases, further pass through protein expression Horizontal analysis is determined.
The extraction and SDS-PAGE electrophoretic analysis of 1.5 mutation lysine decarboxylase CadA
Utilize CIB71, CIB71-RBS-1, CIB71-RBS-2, CIB71-RBS-3, CIB71-RBS-4, CIB71- in 1.4 The bacterium solution of RBS-5, CIB71-RBS-6 mutant strain, and the OD of this several plants of bacterium is adjusted to by phase according to the OD of the bacterial strain measured in 1.4 Same level takes the bacterium solution of the wild type and mutant strain of the same OD of same volume (4ml), 12000rpm to centrifuge 10min, abandon Clearly.The intracellular protein of each bacterial strain is extracted as follows:
1) (the Buffer 1 (pH 8) of buffer 1 of 1ml are used:50mM Tris-HCl pH 8;25mM NaCl;2mM EDTA thalline (hereinafter referred to as sample)) is resuspended;
2) 1hr is frozen for -20 DEG C;
3) 37 DEG C, 15min melts sample;
4) add 5 μ l lysozymes (purchased from precious bioengineering (Dalian) Co., Ltd), and continue to be incubated 3hrs at 37 DEG C, during which Reverse mixing is several times;
5) 1hr is frozen for -20 DEG C;
6) 37 DEG C, 15min melts sample;
7) the DNase I (purchased from precious bioengineering (Dalian) Co., Ltd) of 1 μ l are added, continue to be incubated 1hrs at 37 DEG C;
8) 12000rpm centrifuges 10min, takes in supernatant to a new EP pipe, it is ensured that supernatant does not contain cell fragment;
9) supernatant is stored in 4 DEG C of refrigerators, spare;Precipitation is suspended with the buffer 1 of 1ml, spare.
Each 64 μ l of the intracellular protein supernatant of each bacterial strain are taken respectively, and 5 × SDS-PAGE sample-loading buffers that 16 μ l are added (are matched Side:250mM Tris-HCl (pH6.8), 10% (w/v) SDS, 0.5% (w/v) bromophenol blue, 50% (v/v) glycerine, 5% (v/v) Beta -mercaptoethanol;) the denatured by boiling 10min in boiling water bath, after of short duration cooling, 12000rpm centrifuge 2min, take 10 μ l supernatants into Row SDS-PAGE analyses, as a result as shown in Fig. 1.It can be seen that mutant strain CIB71-RBS-1, CIB71-RBS-2 and CIB71- The trend that lysine decarboxylase CadA expression quantity in RBS-3 supernatants decreased significantly compared with compareing CIB71, from protein expression The RBS that mutation is demonstrated in level makes the translation rate of lysine decarboxylase occur being remarkably decreased;And CIB71-RBS-4, The lysine decarboxylase of CIB71-RBS-5 and CIB71-RBS-6 mutant strains expression significantly improves compared with the control, also from egg The RBS that these three mutation are demonstrated on white level makes the translation rate of lysine decarboxylase occur significantly rising.
Comparative example 1
The inhibition that the 1,5- pentanediamines of various concentration grow microorganism
The plasmid pCIB71 that lysine decarboxylase CadA will be expressed is converted into Escherichia coli CIB103-2 bacterial strains It arrives
CIB103-71 bacterial strains.The specific construction method of wherein CIB103-2 bacterial strains is as follows:
1. building tetracycline efflux pump (tetracycline effluxpump) expression vector skeleton:
Utilize primer psyn-1 and psyn-2 synthetic promoter sequence (SEQ ID NO:10), wherein primer psyn-1 packets open Promoter sequences and one section of sequence homologous with pUC18, primer psyn-2 include one section of sequence homologous with pUC18, the two PCR Primer is used to expand a part of sequence of the promoter sequence and pUC18 carriers of synthesis, restricted including multiple cloning sites Restriction endonuclease EcoRI and ScaI are used for the DNA fragmentation that digest amplification comes out, and further connect structure in pUC18 and obtain pUC10.
2. building tetracycline efflux pump expression vector:
Utilize primer tetA-F and tetA-R tetracycline efflux pump TetA (SEQ ID NO:11) encoding gene (tetA, SEQ ID NO:12) it, expands and obtains from E. coli cloning vector pBR322, using being connected to after SacI and XbaI double digestions PCIB20 is obtained in pCIB10 plasmids.
3. the structure of three albumen LysC, DapA and LysA reading frames on lysine synthetic pathway:
In genome of E.coli encode Bio-synthetic pathway of lysine on three albumen gene, lysC, dapA and lysA:Aspartokinase (LysC or AKIII, encoded by lysC), dihydrodipicolinate synthase (DapA or DHDPS, by DapA is encoded), diaminopimelate decarboxylase (LysA is encoded by lysA), in these three gene clonings to plasmid vector, thus three A albumen LysC (SEQ ID NO:13),DapA(SEQ ID NO:15),LysA(SEQ ID NO:17) it may be implemented in large intestine Overexpression in bacillus.First with primer lysC-F and lysC-R by gene lysC (SEQ ID NO:14) from Escherichia coli It amplifies and in the genome of E.coli MG1655K12, same double enzymes are connected to later with SacI and BamHI are double digested Plasmid pCIB7 is obtained in the plasmid pUC18 cut.Using primer dapA-F and dapA-R by gene dapA (SEQ ID NO:16) from It amplifies and in the genome of E. coli MG1655K12, be connected to later with BamHI and XbaI are double digested Plasmid pCIB8 is obtained in the plasmid pCIB7 of same double digestion.Using primer lysA-F and lysA-R by gene lysA (SEQ ID NO:18) amplified from the genome of E. coli MG1655K12 come, with XbaI and SalI it is double digested after It is connected in the plasmid pCIB8 of same double digestion and obtains plasmid pCIB9.Further utilize lysC-F and lysA-R by these three Gene is amplified from pCIB9 together to be come, and double digested using SacI and SalI, is connected to the plasmid of same double digestion PCIB32 is obtained in pCIB10.
4. aspartokinase enzyme coding gene mutational vector is built:
In order to improve the yield of lysine, further to aspartokinase gene (LysC or AKIII, by lysC, SEQ ID NO:18 codings) it is mutated, specifically, using primer 318-F, 318-R, 323-F, 323-R expand to obtain LysC-1 (LysC-M318I, G323D, SEQ.ID NO:21) encoding gene lysC-1 (SEQ ID NO:20), and by replacing pCIB32 In wild type lysC, obtain plasmid pCIB43.LysC-1 after mutation can further weaken the feedback inhibition of lysine.
5. building the coexpression vector of other three kinds of albumen Asd, DapB and AspC in lysine synthesis access:
Further, the other three gene asd, dapB and aspC in access is synthesized to lysine to be overexpressed.These Gene is separately encoded following three albumen:Aspartate semialdehyde dehydrogenase (Asd (SEQ ID NO:21), encoded by asd), two Pyridinium hydroxide dicarboxylic acids reductase (DapB or DHDPR (SEQ ID NO:23), encoded by dapB), aspartate transaminase (AspC (SEQ ID NO:25) it, is encoded by aspC).Using primer asd-F and asd-R by asd (SEQ ID NO:22) from Escherichia coli It amplifies and in MG1655K12 genomes, after SacI and BamHI double digestions, be connected to structure in pUC18 and obtain pCIB12;Using primer dapB-F and dapB-R by dapB (SEQ ID NO:24) from Escherichia coli MG1655K12 genomes It amplifies and, after BamHI and XbaI double digestions, be connected to structure in pCIB12 and obtain pCIB13;Utilize primer aspC-F With aspC-R by aspC (SEQ ID NO:26) amplify and from Escherichia coli MG1655K12 genomes, using XbaI and After SalI double digestions, it is connected to structure in pCIB13 and obtains pCIB31;Using primer tetA-F3 and tetA-R3, with plasmid PCIB20 is template, and amplification obtains tetA encoding genes, builds to obtain using pCIB31 is connected into after XhoI and SphI double digestions pCIB59。
6. building six gene co-expressing plasmids in lysine synthesis access:
LysC-1, dapA, and lysA are amplified to come together from pCIB43 using primer LAL-F and LAL-R, After ApaI and KpnI double digestions, it is connect with the plasmid pCIB59 of same double digestion, obtains pCIB103-2 plasmids.
7. building CIB103-2 bacterial strains:
The pCIB103-2 plasmids built are converted into e. coli bl21, Escherichia coli CIB103-2 bacterial strains are obtained.
Respectively picking CIB103-71 bacterial strains monoclonal to containing various concentration (0,5,10,15,20,25,30,35, The culture medium of 1,5- pentanediamines 40g/L) (contains 4% in 5mL fluid nutrient mediums<Mass percent, following components are same>Grape Sugar, 0.1%KH2PO4, 0.1%MgSO4, 1.6% (NH4)2SO4, 0.001%FeSO4, 0.001%MnSO4, the extraction of 0.2% yeast Object (is purchased from England OXOID LTD.), 0.05%L- methionine, 0.01%L- threonines, 0.005%L- isoleucines, 10 μ G/mL tetracyclines) in, in 37 DEG C, (instrument is purchased from Shanghai Shiping Experiment Equipment Co., Ltd. to 250rpm, and type low capacity free from worldly cares is entirely warm Spend constant temperature culture oscillator, model SPH-200B) overnight incubation (for 24 hours), it is dense using each 1,5- pentanediamines of spectrophotometric determination The OD of degree condition hypothallus562nm.As a result as shown in Fig. 2, it can be seen that when 1,5- pentanediamines concentration gradually increases from 0 to 20g/L The OD of added-time, thalline drastically decline;After 1,5- pentanediamine concentration is more than 20g/L, it is nearly no detectable thalli growth.
Embodiment 2
Strains for Lysine Production One-step production 1,5- pentanediamines
By wild plasmid pCIB71 and random mutation screen containing lysine acid decarboxylase expression quantity can be caused The mutant plasmid (pCIB71-RBS1, pCIB71-RBS2, pCIB71-RBS3) of the RBS sequences of reduction is converted respectively to can give birth to In the Escherichia coli CIB103-2 for producing lysine, CIB103-71, CIB103-71-RBS1, CIB103-71-RBS2 are respectively obtained With CIB103-71-RBS3 bacterial strains.As a contrast with CIB103-2 bacterial strains, respectively in picking monoclonal to 5mL fluid nutrient mediums (contain 4%<Mass percent, following components are same>Glucose, 0.1%KH2PO4, 0.1%MgSO4, 1.6% (NH4)2SO4, 0.001%FeSO4, 0.001%MnSO4, 0.2% yeast extract (purchased from England OXOID LTD.), 0.05%L- egg ammonia Acid, 0.01%L- threonines, 0.005%L- isoleucines, 10 μ g/mL tetracyclines, 100 μ g/mL ampicillins), in 37 DEG C, (instrument is purchased from Shanghai Shiping Experiment Equipment Co., Ltd., type low capacity total temperature constant temperature culture oscillator free from worldly cares, model to 250rpm SPH-200B) overnight incubation (for 24 hours).Second day, each bacterial strain be switched to again 100ml it is fresh contain 30g/L glucose, 0.7% (mass percent) Ca (HCO3)2, in 37 DEG C in the culture medium of 10 μ g/mL tetracyclines and 100 μ g/mL ampicillins, (instrument is purchased from Shanghai Shiping Experiment Equipment Co., Ltd., standard type large capacity constant-temperature shaking incubator, model SPH- to 170rpm 211B) continue culture 72 hours, the lysine in each culture medium and 1, the content (table of 5- pentanediamines are detected and calculated using nuclear-magnetism 4).As shown in table 4, with mutant strain CIB103-71-RBS3, the expression of CIB103-71-RBS2 and CIB103-71-RBS1 bacterial strains The amount of lysine decarboxylase continuously decrease, the yield of 1,5- pentanediamine gradually rises, and also means that more lysines hairs Conversion has been given birth to, lysine has thus been may be decreased relevant enzyme is synthesized to lysine and checked, the yield of lysine also can be into one Step increases and is converted into 1,5- pentanediamines, is embodied in the L-lysine and 1 of measurement, the total amount of 5- pentanediamines gradually rises.
Table 4. detects the bacterial strain lysine and 1,5- penta 2 that can express lysine synthetic proteins and lysine decarboxylase simultaneously The level of amine.
SEQUENCE LISTING
<110>Shanghai Cathay Biological Technology Research Center Co., Ltd
Kai Sai biological industrys Co., Ltd
<120>A kind of ribosome bind site, recombinant expression plasmid, transformant and its application
<130> PA16011-2
<160> 56
<170> PatentIn version 3.5
<210> 1
<211> 715
<212> PRT
<213> Escherichia coli
<400> 1
Met Asn Val Ile Ala Ile Leu Asn His Met Gly Val Tyr Phe Lys Glu
1 5 10 15
Glu Pro Ile Arg Glu Leu His Arg Ala Leu Glu Arg Leu Asn Phe Gln
20 25 30
Ile Val Tyr Pro Asn Asp Arg Asp Asp Leu Leu Lys Leu Ile Glu Asn
35 40 45
Asn Ala Arg Leu Cys Gly Val Ile Phe Asp Trp Asp Lys Tyr Asn Leu
50 55 60
Glu Leu Cys Glu Glu Ile Ser Lys Met Asn Glu Asn Leu Pro Leu Tyr
65 70 75 80
Ala Phe Ala Asn Thr Tyr Ser Thr Leu Asp Val Ser Leu Asn Asp Leu
85 90 95
Arg Leu Gln Ile Ser Phe Phe Glu Tyr Ala Leu Gly Ala Ala Glu Asp
100 105 110
Ile Ala Asn Lys Ile Lys Gln Thr Thr Asp Glu Tyr Ile Asn Thr Ile
115 120 125
Leu Pro Pro Leu Thr Lys Ala Leu Phe Lys Tyr Val Arg Glu Gly Lys
130 135 140
Tyr Thr Phe Cys Thr Pro Gly His Met Gly Gly Thr Ala Phe Gln Lys
145 150 155 160
Ser Pro Val Gly Ser Leu Phe Tyr Asp Phe Phe Gly Pro Asn Thr Met
165 170 175
Lys Ser Asp Ile Ser Ile Ser Val Ser Glu Leu Gly Ser Leu Leu Asp
180 185 190
His Ser Gly Pro His Lys Glu Ala Glu Gln Tyr Ile Ala Arg Val Phe
195 200 205
Asn Ala Asp Arg Ser Tyr Met Val Thr Asn Gly Thr Ser Thr Ala Asn
210 215 220
Lys Ile Val Gly Met Tyr Ser Ala Pro Ala Gly Ser Thr Ile Leu Ile
225 230 235 240
Asp Arg Asn Cys His Lys Ser Leu Thr His Leu Met Met Met Ser Asp
245 250 255
Val Thr Pro Ile Tyr Phe Arg Pro Thr Arg Asn Ala Tyr Gly Ile Leu
260 265 270
Gly Gly Ile Pro Gln Ser Glu Phe Gln His Ala Thr Ile Ala Lys Arg
275 280 285
Val Lys Glu Thr Pro Asn Ala Thr Trp Pro Val His Ala Val Ile Thr
290 295 300
Asn Ser Thr Tyr Asp Gly Leu Leu Tyr Asn Thr Asp Phe Ile Lys Lys
305 310 315 320
Thr Leu Asp Val Lys Ser Ile His Phe Asp Ser Ala Trp Val Pro Tyr
325 330 335
Thr Asn Phe Ser Pro Ile Tyr Glu Gly Lys Cys Gly Met Ser Gly Gly
340 345 350
Arg Val Glu Gly Lys Val Ile Tyr Glu Thr Gln Ser Thr His Lys Leu
355 360 365
Leu Ala Ala Phe Ser Gln Ala Ser Met Ile His Val Lys Gly Asp Val
370 375 380
Asn Glu Glu Thr Phe Asn Glu Ala Tyr Met Met His Thr Thr Thr Ser
385 390 395 400
Pro His Tyr Gly Ile Val Ala Ser Thr Glu Thr Ala Ala Ala Met Met
405 410 415
Lys Gly Asn Ala Gly Lys Arg Leu Ile Asn Gly Ser Ile Glu Arg Ala
420 425 430
Ile Lys Phe Arg Lys Glu Ile Lys Arg Leu Arg Thr Glu Ser Asp Gly
435 440 445
Trp Phe Phe Asp Val Trp Gln Pro Asp His Ile Asp Thr Thr Glu Cys
450 455 460
Trp Pro Leu Arg Ser Asp Ser Thr Trp His Gly Phe Lys Asn Ile Asp
465 470 475 480
Asn Glu His Met Tyr Leu Asp Pro Ile Lys Val Thr Leu Leu Thr Pro
485 490 495
Gly Met Glu Lys Asp Gly Thr Met Ser Asp Phe Gly Ile Pro Ala Ser
500 505 510
Ile Val Ala Lys Tyr Leu Asp Glu His Gly Ile Val Val Glu Lys Thr
515 520 525
Gly Pro Tyr Asn Leu Leu Phe Leu Phe Ser Ile Gly Ile Asp Lys Thr
530 535 540
Lys Ala Leu Ser Leu Leu Arg Ala Leu Thr Asp Phe Lys Arg Ala Phe
545 550 555 560
Asp Leu Asn Leu Arg Val Lys Asn Met Leu Pro Ser Leu Tyr Arg Glu
565 570 575
Asp Pro Glu Phe Tyr Glu Asn Met Arg Ile Gln Glu Leu Ala Gln Asn
580 585 590
Ile His Lys Leu Ile Val His His Asn Leu Pro Asp Leu Met Tyr Arg
595 600 605
Ala Phe Glu Val Leu Pro Thr Met Val Met Thr Pro Tyr Ala Ala Phe
610 615 620
Gln Lys Glu Leu His Gly Met Thr Glu Glu Val Tyr Leu Asp Glu Met
625 630 635 640
Val Gly Arg Ile Asn Ala Asn Met Ile Leu Pro Tyr Pro Pro Gly Val
645 650 655
Pro Leu Val Met Pro Gly Glu Met Ile Thr Glu Glu Ser Arg Pro Val
660 665 670
Leu Glu Phe Leu Gln Met Leu Cys Glu Ile Gly Ala His Tyr Pro Gly
675 680 685
Phe Glu Thr Asp Ile His Gly Ala Tyr Arg Gln Ala Asp Gly Arg Tyr
690 695 700
Thr Val Lys Val Leu Lys Glu Glu Ser Lys Lys
705 710 715
<210> 2
<211> 2148
<212> DNA
<213> Escherichia coli
<400> 2
atgaacgtta ttgcaatatt gaatcacatg ggggtttatt ttaaagaaga acccatccgt 60
gaacttcatc gcgcgcttga acgtctgaac ttccagattg tttacccgaa cgaccgtgac 120
gacttattaa aactgatcga aaacaatgcg cgtctgtgcg gcgttatttt tgactgggat 180
aaatataatc tcgagctgtg cgaagaaatt agcaaaatga acgagaacct gccgttgtac 240
gcgttcgcta atacgtattc cactctcgat gtaagcctga atgacctgcg tttacagatt 300
agcttctttg aatatgcgct gggtgctgct gaagatattg ctaataagat caagcagacc 360
actgacgaat atatcaacac tattctgcct ccgctgacta aagcactgtt taaatatgtt 420
cgtgaaggta aatatacttt ctgtactcct ggtcacatgg gcggtactgc attccagaaa 480
agcccggtag gtagcctgtt ctatgatttc tttggtccga ataccatgaa atctgatatt 540
tccatttcag tatctgaact gggttctctg ctggatcaca gtggtccaca caaagaagca 600
gaacagtata tcgctcgcgt ctttaacgca gaccgcagct acatggtgac caacggtact 660
tccactgcga acaaaattgt tggtatgtac tctgctccag caggcagcac cattctgatt 720
gaccgtaact gccacaaatc gctgacccac ctgatgatga tgagcgatgt tacgccaatc 780
tatttccgcc cgacccgtaa cgcttacggt attcttggtg gtatcccaca gagtgaattc 840
cagcacgcta ccattgctaa gcgcgtgaaa gaaacaccaa acgcaacctg gccggtacat 900
gctgtaatta ccaactctac ctatgatggt ctgctgtaca acaccgactt catcaagaaa 960
acactggatg tgaaatccat ccactttgac tccgcgtggg tgccttacac caacttctca 1020
ccgatttacg aaggtaaatg cggtatgagc ggtggccgtg tagaagggaa agtgatttac 1080
gaaacccagt ccactcacaa actgctggcg gcgttctctc aggcttccat gatccacgtt 1140
aaaggtgacg taaacgaaga aacctttaac gaagcctaca tgatgcacac caccacttct 1200
ccgcactacg gtatcgtggc gtccactgaa accgctgcgg cgatgatgaa aggcaatgca 1260
ggtaagcgtc tgatcaacgg ttctattgaa cgtgcgatca aattccgtaa agagatcaaa 1320
cgtctgagaa cggaatctga tggctggttc tttgatgtat ggcagccgga tcatatcgat 1380
acgactgaat gctggccgct gcgttctgac agcacctggc acggcttcaa aaacatcgat 1440
aacgagcaca tgtatcttga cccgatcaaa gtcaccctgc tgactccggg gatggaaaaa 1500
gacggcacca tgagcgactt tggtattccg gccagcatcg tggcgaaata cctcgacgaa 1560
catggcatcg ttgttgagaa aaccggtccg tataacctgc tgttcctgtt cagcatcggt 1620
atcgataaga ccaaagcact gagcctgctg cgtgctctga ctgactttaa acgtgcgttc 1680
gacctgaacc tgcgtgtgaa aaacatgctg ccgtctctgt atcgtgaaga tcctgaattc 1740
tatgaaaaca tgcgtattca ggaactggct cagaatatcc acaaactgat tgttcaccac 1800
aatctgccgg atctgatgta tcgcgcattt gaagtgctgc cgacgatggt aatgactccg 1860
tatgctgcat tccagaaaga gctgcacggt atgaccgaag aagtttacct cgacgaaatg 1920
gtaggtcgta ttaacgccaa tatgatcctt ccgtacccgc cgggagttcc tctggtaatg 1980
ccgggtgaaa tgatcaccga agaaagccgt ccggttctgg agttcctgca gatgctgtgt 2040
gaaatcggcg ctcactatcc gggctttgaa accgatattc acggtgcata ccgtcaggct 2100
gatggccgct ataccgttaa ggtattgaaa gaagaaagca aaaaataa 2148
<210> 3
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA-RBS
<400> 3
ggataacaat ttcacacagg aaacagct 28
<210> 4
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-1
<400> 4
ggataacaat ttcgtcatca aaacagct 28
<210> 5
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-2
<400> 5
ggataacaat ttccgcaaag atacagct 28
<210> 6
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-3
<400> 6
ggataacaat ttcaaagatt taccagct 28
<210> 7
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-4
<400> 7
ggataacaat ttcgagagga ggacagct 28
<210> 8
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-5
<400> 8
ggataacaat ttcaagggaa attcagct 28
<210> 9
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> cadA RBS-6
<400> 9
ggataacaat ttcttaaaga gggcagct 28
<210> 10
<211> 38
<212> DNA
<213> Artificial Sequence
<220>
<223> Promoter
<400> 10
agtttattct tgacatgtag tgagggggct ggtataat 38
<210> 11
<211> 396
<212> PRT
<213> Artificial Sequence
<220>
<223> TetA
<400> 11
Met Lys Ser Asn Asn Ala Leu Ile Val Ile Leu Gly Thr Val Thr Leu
1 5 10 15
Asp Ala Val Gly Ile Gly Leu Val Met Pro Val Leu Pro Gly Leu Leu
20 25 30
Arg Asp Ile Val His Ser Asp Ser Ile Ala Ser His Tyr Gly Val Leu
35 40 45
Leu Ala Leu Tyr Ala Leu Met Gln Phe Leu Cys Ala Pro Val Leu Gly
50 55 60
Ala Leu Ser Asp Arg Phe Gly Arg Arg Pro Val Leu Leu Ala Ser Leu
65 70 75 80
Leu Gly Ala Thr Ile Asp Tyr Ala Ile Met Ala Thr Thr Pro Val Leu
85 90 95
Trp Ile Leu Tyr Ala Gly Arg Ile Val Ala Gly Ile Thr Gly Ala Thr
100 105 110
Gly Ala Val Ala Gly Ala Tyr Ile Ala Asp Ile Thr Asp Gly Glu Asp
115 120 125
Arg Ala Arg His Phe Gly Leu Met Ser Ala Cys Phe Gly Val Gly Met
130 135 140
Val Ala Gly Pro Val Ala Gly Gly Leu Leu Gly Ala Ile Ser Leu His
145 150 155 160
Ala Pro Phe Leu Ala Ala Ala Val Leu Asn Gly Leu Asn Leu Leu Leu
165 170 175
Gly Cys Phe Leu Met Gln Glu Ser His Lys Gly Glu Arg Arg Pro Met
180 185 190
Pro Leu Arg Ala Phe Asn Pro Val Ser Ser Phe Arg Trp Ala Arg Gly
195 200 205
Met Thr Ile Val Ala Ala Leu Met Thr Val Phe Phe Ile Met Gln Leu
210 215 220
Val Gly Gln Val Pro Ala Ala Leu Trp Val Ile Phe Gly Glu Asp Arg
225 230 235 240
Phe Arg Trp Ser Ala Thr Met Ile Gly Leu Ser Leu Ala Val Phe Gly
245 250 255
Ile Leu His Ala Leu Ala Gln Ala Phe Val Thr Gly Pro Ala Thr Lys
260 265 270
Arg Phe Gly Glu Lys Gln Ala Ile Ile Ala Gly Met Ala Ala Asp Ala
275 280 285
Leu Gly Tyr Val Leu Leu Ala Phe Ala Thr Arg Gly Trp Met Ala Phe
290 295 300
Pro Ile Met Ile Leu Leu Ala Ser Gly Gly Ile Gly Met Pro Ala Leu
305 310 315 320
Gln Ala Met Leu Ser Arg Gln Val Asp Asp Asp His Gln Gly Gln Leu
325 330 335
Gln Gly Ser Leu Ala Ala Leu Thr Ser Leu Thr Ser Ile Ile Gly Pro
340 345 350
Leu Ile Val Thr Ala Ile Tyr Ala Ala Ser Ala Ser Thr Trp Asn Gly
355 360 365
Leu Ala Trp Ile Val Gly Ala Ala Leu Tyr Leu Val Cys Leu Pro Ala
370 375 380
Leu Arg Arg Gly Ala Trp Ser Arg Ala Thr Ser Thr
385 390 395
<210> 12
<211> 1191
<212> DNA
<213> Artificial Sequence
<220>
<223> tetA
<400> 12
atgaaatcta acaatgcgct catcgtcatc ctcggcaccg tcaccctgga tgctgtaggc 60
ataggcttgg ttatgccggt actgccgggc ctcttgcggg atatcgtcca ttccgacagc 120
atcgccagtc actatggcgt gctgctagcg ctatatgcgt tgatgcaatt tctatgcgca 180
cccgttctcg gagcactgtc cgaccgcttt ggccgccgcc cagtcctgct cgcttcgcta 240
cttggagcca ctatcgacta cgcgatcatg gcgaccacac ccgtcctgtg gatcctctac 300
gccggacgca tcgtggccgg catcaccggc gccacaggtg cggttgctgg cgcctatatc 360
gccgacatca ccgatgggga agatcgggct cgccacttcg ggctcatgag cgcttgtttc 420
ggcgtgggta tggtggcagg ccccgtggcc gggggactgt tgggcgccat ctccttgcat 480
gcaccattcc ttgcggcggc ggtgctcaac ggcctcaacc tactactggg ctgcttccta 540
atgcaggagt cgcataaggg agagcgtcga ccgatgccct tgagagcctt caacccagtc 600
agctccttcc ggtgggcgcg gggcatgact atcgtcgccg cacttatgac tgtcttcttt 660
atcatgcaac tcgtaggaca ggtgccggca gcgctctggg tcattttcgg cgaggaccgc 720
tttcgctgga gcgcgacgat gatcggcctg tcgcttgcgg tattcggaat cttgcacgcc 780
ctcgctcaag ccttcgtcac tggtcccgcc accaaacgtt tcggcgagaa gcaggccatt 840
atcgccggca tggcggccga cgcgctgggc tacgtcttgc tggcgttcgc gacgcgaggc 900
tggatggcct tccccattat gattcttctc gcttccggcg gcatcgggat gcccgcgttg 960
caggccatgc tgtccaggca ggtagatgac gaccatcagg gacagcttca aggatcgctc 1020
gcggctctta ccagcctaac ttcgatcatt ggaccgctga tcgtcacggc gatttatgcc 1080
gcctcggcga gcacatggaa cgggttggca tggattgtag gcgccgccct ataccttgtc 1140
tgcctccccg cgttgcgtcg cggtgcatgg agccgggcca cctcgacctg a 1191
<210> 13
<211> 449
<212> PRT
<213> Escherichia coli
<400> 13
Met Ser Glu Ile Val Val Ser Lys Phe Gly Gly Thr Ser Val Ala Asp
1 5 10 15
Phe Asp Ala Met Asn Arg Ser Ala Asp Ile Val Leu Ser Asp Ala Asn
20 25 30
Val Arg Leu Val Val Leu Ser Ala Ser Ala Gly Ile Thr Asn Leu Leu
35 40 45
Val Ala Leu Ala Glu Gly Leu Glu Pro Gly Glu Arg Phe Glu Lys Leu
50 55 60
Asp Ala Ile Arg Asn Ile Gln Phe Ala Ile Leu Glu Arg Leu Arg Tyr
65 70 75 80
Pro Asn Val Ile Arg Glu Glu Ile Glu Arg Leu Leu Glu Asn Ile Thr
85 90 95
Val Leu Ala Glu Ala Ala Ala Leu Ala Thr Ser Pro Ala Leu Thr Asp
100 105 110
Glu Leu Val Ser His Gly Glu Leu Met Ser Thr Leu Leu Phe Val Glu
115 120 125
Ile Leu Arg Glu Arg Asp Val Gln Ala Gln Trp Phe Asp Val Arg Lys
130 135 140
Val Met Arg Thr Asn Asp Arg Phe Gly Arg Ala Glu Pro Asp Ile Ala
145 150 155 160
Ala Leu Ala Glu Leu Ala Ala Leu Gln Leu Leu Pro Arg Leu Asn Glu
165 170 175
Gly Leu Val Ile Thr Gln Gly Phe Ile Gly Ser Glu Asn Lys Gly Arg
180 185 190
Thr Thr Thr Leu Gly Arg Gly Gly Ser Asp Tyr Thr Ala Ala Leu Leu
195 200 205
Ala Glu Ala Leu His Ala Ser Arg Val Asp Ile Trp Thr Asp Val Pro
210 215 220
Gly Ile Tyr Thr Thr Asp Pro Arg Val Val Ser Ala Ala Lys Arg Ile
225 230 235 240
Asp Glu Ile Ala Phe Ala Glu Ala Ala Glu Met Ala Thr Phe Gly Ala
245 250 255
Lys Val Leu His Pro Ala Thr Leu Leu Pro Ala Val Arg Ser Asp Ile
260 265 270
Pro Val Phe Val Gly Ser Ser Lys Asp Pro Arg Ala Gly Gly Thr Leu
275 280 285
Val Cys Asn Lys Thr Glu Asn Pro Pro Leu Phe Arg Ala Leu Ala Leu
290 295 300
Arg Arg Asn Gln Thr Leu Leu Thr Leu His Ser Leu Asn Met Leu His
305 310 315 320
Ser Arg Gly Phe Leu Ala Glu Val Phe Gly Ile Leu Ala Arg His Asn
325 330 335
Ile Ser Val Asp Leu Ile Thr Thr Ser Glu Val Ser Val Ala Leu Thr
340 345 350
Leu Asp Thr Thr Gly Ser Thr Ser Thr Gly Asp Thr Leu Leu Thr Gln
355 360 365
Ser Leu Leu Met Glu Leu Ser Ala Leu Cys Arg Val Glu Val Glu Glu
370 375 380
Gly Leu Ala Leu Val Ala Leu Ile Gly Asn Asp Leu Ser Lys Ala Cys
385 390 395 400
Gly Val Gly Lys Glu Val Phe Gly Val Leu Glu Pro Phe Asn Ile Arg
405 410 415
Met Ile Cys Tyr Gly Ala Ser Ser His Asn Leu Cys Phe Leu Val Pro
420 425 430
Gly Glu Asp Ala Glu Gln Val Val Gln Lys Leu His Ser Asn Leu Phe
435 440 445
Glu
<210> 14
<211> 1350
<212> DNA
<213> Escherichia coli
<400> 14
atgtctgaaa ttgttgtctc caaatttggc ggtaccagcg tagctgattt tgacgccatg 60
aaccgcagcg ctgatattgt gctttctgat gccaacgtgc gtttagttgt cctctcggct 120
tctgctggta tcactaatct gctggtcgct ttagctgaag gactggaacc tggcgagcga 180
ttcgaaaaac tcgacgctat ccgcaacatc cagtttgcca ttctggaacg tctgcgttac 240
ccgaacgtta tccgtgaaga gattgaacgt ctgctggaga acattactgt tctggcagaa 300
gcggcggcgc tggcaacgtc tccggcgctg acagatgagc tggtcagcca cggcgagctg 360
atgtcgaccc tgctgtttgt tgagatcctg cgcgaacgcg atgttcaggc acagtggttt 420
gatgtacgta aagtgatgcg taccaacgac cgatttggtc gtgcagagcc agatatagcc 480
gcgctggcgg aactggccgc gctgcagctg ctcccacgtc tcaatgaagg cttagtgatc 540
acccagggat ttatcggtag cgaaaataaa ggtcgtacaa cgacgcttgg ccgtggaggc 600
agcgattata cggcagcctt gctggcggag gctttacacg catctcgtgt tgatatctgg 660
accgacgtcc cgggcatcta caccaccgat ccacgcgtag tttccgcagc aaaacgcatt 720
gatgaaatcg cgtttgccga agcggcagag atggcaactt ttggtgcaaa agtactgcat 780
ccggcaacgt tgctacccgc agtacgcagc gatatcccgg tctttgtcgg ctccagcaaa 840
gacccacgcg caggtggtac gctggtgtgc aataaaactg aaaatccgcc gctgttccgc 900
gctctggcgc ttcgtcgcaa tcagactctg ctcactttgc acagcctgaa tatgctgcat 960
tctcgcggtt tcctcgcgga agttttcggc atcctcgcgc ggcataatat ttcggtagac 1020
ttaatcacca cgtcagaagt gagcgtggca ttaacccttg ataccaccgg ttcaacctcc 1080
actggcgata cgttgctgac gcaatctctg ctgatggagc tttccgcact gtgtcgggtg 1140
gaggtggaag aaggtctggc gctggtcgcg ttgattggca atgacctgtc aaaagcctgc 1200
ggcgttggca aagaggtatt cggcgtactg gaaccgttca acattcgcat gatttgttat 1260
ggcgcatcca gccataacct gtgcttcctg gtgcccggcg aagatgccga gcaggtggtg 1320
caaaaactgc atagtaattt gtttgagtaa 1350
<210> 15
<211> 292
<212> PRT
<213> Escherichia coli
<400> 15
Met Phe Thr Gly Ser Ile Val Ala Ile Val Thr Pro Met Asp Glu Lys
1 5 10 15
Gly Asn Val Cys Arg Ala Ser Leu Lys Lys Leu Ile Asp Tyr His Val
20 25 30
Ala Ser Gly Thr Ser Ala Ile Val Ser Val Gly Thr Thr Gly Glu Ser
35 40 45
Ala Thr Leu Asn His Asp Glu His Ala Asp Val Val Met Met Thr Leu
50 55 60
Asp Leu Ala Asp Gly Arg Ile Pro Val Ile Ala Gly Thr Gly Ala Asn
65 70 75 80
Ala Thr Ala Glu Ala Ile Ser Leu Thr Gln Arg Phe Asn Asp Ser Gly
85 90 95
Ile Val Gly Cys Leu Thr Val Thr Pro Tyr Tyr Asn Arg Pro Ser Gln
100 105 110
Glu Gly Leu Tyr Gln His Phe Lys Ala Ile Ala Glu His Thr Asp Leu
115 120 125
Pro Gln Ile Leu Tyr Asn Val Pro Ser Arg Thr Gly Cys Asp Leu Leu
130 135 140
Pro Glu Thr Val Gly Arg Leu Ala Lys Val Lys Asn Ile Ile Gly Ile
145 150 155 160
Lys Glu Ala Thr Gly Asn Leu Thr Arg Val Asn Gln Ile Lys Glu Leu
165 170 175
Val Ser Asp Asp Phe Val Leu Leu Ser Gly Asp Asp Ala Ser Ala Leu
180 185 190
Asp Phe Met Gln Leu Gly Gly His Gly Val Ile Ser Val Thr Ala Asn
195 200 205
Val Ala Ala Arg Asp Met Ala Gln Met Cys Lys Leu Ala Ala Glu Gly
210 215 220
His Phe Ala Glu Ala Arg Val Ile Asn Gln Arg Leu Met Pro Leu His
225 230 235 240
Asn Lys Leu Phe Val Glu Pro Asn Pro Ile Pro Val Lys Trp Ala Cys
245 250 255
Lys Glu Leu Gly Leu Val Ala Thr Asp Thr Leu Arg Leu Pro Met Thr
260 265 270
Pro Ile Thr Asp Ser Gly Arg Glu Thr Val Arg Ala Ala Leu Lys His
275 280 285
Ala Gly Leu Leu
290
<210> 16
<211> 879
<212> DNA
<213> Escherichia coli
<400> 16
atgttcacgg gaagtattgt cgcgattgtt actccgatgg atgaaaaagg taatgtctgt 60
cgggctagct tgaaaaaact gattgattat catgtcgcca gcggtacttc ggcgatcgtt 120
tctgttggca ccactggcga gtccgctacc ttaaatcatg acgaacatgc tgatgtggtg 180
atgatgacgc tggatctggc tgatgggcgc attccggtaa ttgccgggac cggcgctaac 240
gctactgcgg aagccattag cctgacgcag cgcttcaatg acagtggtat cgtcggctgc 300
ctgacggtaa ccccttacta caatcgtccg tcgcaagaag gtttgtatca gcatttcaaa 360
gccatcgctg agcatactga cctgccgcaa attctgtata atgtgccgtc ccgtactggc 420
tgcgatctgc tcccggaaac ggtgggccgt ctggcgaaag taaaaaatat tatcggaatc 480
aaagaggcaa cagggaactt aacgcgtgta aaccagatca aagagctggt ttcagatgat 540
tttgttctgc tgagcggcga tgatgcgagc gcgctggact tcatgcaatt gggcggtcat 600
ggggttattt ccgttacggc taacgtcgca gcgcgtgata tggcccagat gtgcaaactg 660
gcagcagaag ggcattttgc cgaggcacgc gttattaatc agcgtctgat gccattacac 720
aacaaactat ttgtcgaacc caatccaatc ccggtgaaat gggcatgtaa ggaactgggt 780
cttgtggcga ccgatacgct gcgcctgcca atgacaccaa tcaccgacag tggtcgtgag 840
acggtcagag cggcgcttaa gcatgccggt ttgctgtaa 879
<210> 17
<211> 420
<212> PRT
<213> Escherichia coli
<400> 17
Met Pro His Ser Leu Phe Ser Thr Asp Thr Asp Leu Thr Ala Glu Asn
1 5 10 15
Leu Leu Arg Leu Pro Ala Glu Phe Gly Cys Pro Val Trp Val Tyr Asp
20 25 30
Ala Gln Ile Ile Arg Arg Gln Ile Ala Ala Leu Lys Gln Phe Asp Val
35 40 45
Val Arg Phe Ala Gln Lys Ala Cys Ser Asn Ile His Ile Leu Arg Leu
50 55 60
Met Arg Glu Gln Gly Val Lys Val Asp Ser Val Ser Leu Gly Glu Ile
65 70 75 80
Glu Arg Ala Leu Ala Ala Gly Tyr Asn Pro Gln Thr His Pro Asp Asp
85 90 95
Ile Val Phe Thr Ala Asp Val Ile Asp Gln Ala Thr Leu Glu Arg Val
100 105 110
Ser Glu Leu Gln Ile Pro Val Asn Ala Gly Ser Val Asp Met Leu Asp
115 120 125
Gln Leu Gly Gln Val Ser Pro Gly His Arg Val Trp Leu Arg Val Asn
130 135 140
Pro Gly Phe Gly His Gly His Ser Gln Lys Thr Asn Thr Gly Gly Glu
145 150 155 160
Asn Ser Lys His Gly Ile Trp Tyr Thr Asp Leu Pro Ala Ala Leu Asp
165 170 175
Val Ile Gln Arg His His Leu Gln Leu Val Gly Ile His Met His Ile
180 185 190
Gly Ser Gly Val Asp Tyr Ala His Leu Glu Gln Val Cys Gly Ala Met
195 200 205
Val Arg Gln Val Ile Glu Phe Gly Gln Asp Leu Gln Ala Ile Ser Ala
210 215 220
Gly Gly Gly Leu Ser Val Pro Tyr Gln Gln Gly Glu Glu Ala Val Asp
225 230 235 240
Thr Glu His Tyr Tyr Gly Leu Trp Asn Ala Ala Arg Glu Gln Ile Ala
245 250 255
Arg His Leu Gly His Pro Val Lys Leu Glu Ile Glu Pro Gly Arg Phe
260 265 270
Leu Val Ala Gln Ser Gly Val Leu Ile Thr Gln Val Arg Ser Val Lys
275 280 285
Gln Met Gly Ser Arg His Phe Val Leu Val Asp Ala Gly Phe Asn Asp
290 295 300
Leu Met Arg Pro Ala Met Tyr Gly Ser Tyr His His Ile Ser Ala Leu
305 310 315 320
Ala Ala Asp Gly Arg Ser Leu Glu His Ala Pro Thr Val Glu Thr Val
325 330 335
Val Ala Gly Pro Leu Cys Glu Ser Gly Asp Val Phe Thr Gln Gln Glu
340 345 350
Gly Gly Asn Val Glu Thr Arg Ala Leu Pro Glu Val Lys Ala Gly Asp
355 360 365
Tyr Leu Val Leu His Asp Thr Gly Ala Tyr Gly Ala Ser Met Ser Ser
370 375 380
Asn Tyr Asn Ser Arg Pro Leu Leu Pro Glu Val Leu Phe Asp Asn Gly
385 390 395 400
Gln Ala Arg Leu Ile Arg Arg Arg Gln Thr Ile Glu Glu Leu Leu Ala
405 410 415
Leu Glu Leu Leu
420
<210> 18
<211> 1263
<212> DNA
<213> Escherichia coli
<400> 18
atgccacatt cactgttcag caccgatacc gatctcaccg ccgaaaatct gctgcgtttg 60
cccgctgaat ttggctgccc ggtgtgggtc tacgatgcgc aaattattcg tcggcagatt 120
gcagcgctga aacagtttga tgtggtgcgc tttgcacaga aagcctgttc caatattcat 180
attttgcgct taatgcgtga gcagggcgtg aaagtggatt ccgtctcgtt aggcgaaata 240
gagcgtgcgt tggcggcggg ttacaatccg caaacgcacc ccgatgatat tgtttttacg 300
gcagatgtta tcgatcaggc gacgcttgaa cgcgtcagtg aattgcaaat tccggtgaat 360
gcgggttctg ttgatatgct cgaccaactg ggccaggttt cgccagggca tcgggtatgg 420
ctgcgcgtta atccggggtt tggtcacgga catagccaaa aaaccaatac cggtggcgaa 480
aacagcaagc acggtatctg gtacaccgat ctgcccgccg cactggacgt gatacaacgt 540
catcatctgc agctggtcgg cattcacatg cacattggtt ctggcgttga ttatgcccat 600
ctggaacagg tgtgtggtgc tatggtgcgt caggtcatcg aattcggtca ggatttacag 660
gctatttctg cgggcggtgg gctttctgtt ccttatcaac agggtgaaga ggcggttgat 720
accgaacatt attatggtct gtggaatgcc gcgcgtgagc aaatcgcccg ccatttgggc 780
caccctgtga aactggaaat tgaaccgggt cgcttcctgg tagcgcagtc tggcgtatta 840
attactcagg tgcggagcgt caaacaaatg gggagccgcc actttgtgct ggttgatgcc 900
gggttcaacg atctgatgcg cccggcaatg tacggtagtt accaccatat cagtgccctg 960
gcagctgatg gtcgttctct ggaacacgcg ccaacggtgg aaaccgtcgt cgccggaccg 1020
ttatgtgaat cgggcgatgt ctttacccag caggaagggg gaaatgttga aacccgcgcc 1080
ttgccggaag tgaaggcagg tgattatctg gtactgcatg atacaggggc atatggcgca 1140
tcaatgtcat ccaactacaa tagccgtccg ctgttaccag aagttctgtt tgataatggt 1200
caggcgcggt tgattcgccg tcgccagacc atcgaagaat tactggcgct ggaattgctt 1260
taa 1263
<210> 19
<211> 449
<212> PRT
<213> Artificial Sequence
<220>
<223> LysC-1
<400> 19
Met Ser Glu Ile Val Val Ser Lys Phe Gly Gly Thr Ser Val Ala Asp
1 5 10 15
Phe Asp Ala Met Asn Arg Ser Ala Asp Ile Val Leu Ser Asp Ala Asn
20 25 30
Val Arg Leu Val Val Leu Ser Ala Ser Ala Gly Ile Thr Asn Leu Leu
35 40 45
Val Ala Leu Ala Glu Gly Leu Glu Pro Gly Glu Arg Phe Glu Lys Leu
50 55 60
Asp Ala Ile Arg Asn Ile Gln Phe Ala Ile Leu Glu Arg Leu Arg Tyr
65 70 75 80
Pro Asn Val Ile Arg Glu Glu Ile Glu Arg Leu Leu Glu Asn Ile Thr
85 90 95
Val Leu Ala Glu Ala Ala Ala Leu Ala Thr Ser Pro Ala Leu Thr Asp
100 105 110
Glu Leu Val Ser His Gly Glu Leu Met Ser Thr Leu Leu Phe Val Glu
115 120 125
Ile Leu Arg Glu Arg Asp Val Gln Ala Gln Trp Phe Asp Val Arg Lys
130 135 140
Val Met Arg Thr Asn Asp Arg Phe Gly Arg Ala Glu Pro Asp Ile Ala
145 150 155 160
Ala Leu Ala Glu Leu Ala Ala Leu Gln Leu Leu Pro Arg Leu Asn Glu
165 170 175
Gly Leu Val Ile Thr Gln Gly Phe Ile Gly Ser Glu Asn Lys Gly Arg
180 185 190
Thr Thr Thr Leu Gly Arg Gly Gly Ser Asp Tyr Thr Ala Ala Leu Leu
195 200 205
Ala Glu Ala Leu His Ala Ser Arg Val Asp Ile Trp Thr Asp Val Pro
210 215 220
Gly Ile Tyr Thr Thr Asp Pro Arg Val Val Ser Ala Ala Lys Arg Ile
225 230 235 240
Asp Glu Ile Ala Phe Ala Glu Ala Ala Glu Met Ala Thr Phe Gly Ala
245 250 255
Lys Val Leu His Pro Ala Thr Leu Leu Pro Ala Val Arg Ser Asp Ile
260 265 270
Pro Val Phe Val Gly Ser Ser Lys Asp Pro Arg Ala Gly Gly Thr Leu
275 280 285
Val Cys Asn Lys Thr Glu Asn Pro Pro Leu Phe Arg Ala Leu Ala Leu
290 295 300
Arg Arg Asn Gln Thr Leu Leu Thr Leu His Ser Leu Asn Ile Leu His
305 310 315 320
Ser Arg Asp Phe Leu Ala Glu Val Phe Gly Ile Leu Ala Arg His Asn
325 330 335
Ile Ser Val Asp Leu Ile Thr Thr Ser Glu Val Ser Val Ala Leu Thr
340 345 350
Leu Asp Thr Thr Gly Ser Thr Ser Thr Gly Asp Thr Leu Leu Thr Gln
355 360 365
Ser Leu Leu Met Glu Leu Ser Ala Leu Cys Arg Val Glu Val Glu Glu
370 375 380
Gly Leu Ala Leu Val Ala Leu Ile Gly Asn Asp Leu Ser Lys Ala Cys
385 390 395 400
Gly Val Gly Lys Glu Val Phe Gly Val Leu Glu Pro Phe Asn Ile Arg
405 410 415
Met Ile Cys Tyr Gly Ala Ser Ser His Asn Leu Cys Phe Leu Val Pro
420 425 430
Gly Glu Asp Ala Glu Gln Val Val Gln Lys Leu His Ser Asn Leu Phe
435 440 445
Glu
<210> 20
<211> 1349
<212> DNA
<213> Artificial Sequence
<220>
<223> lysC-1
<400> 20
tgtctgaaat tgttgtctcc aaatttggcg gtaccagcgt agctgatttt gacgccatga 60
accgcagcgc tgatattgtg ctttctgatg ccaacgtgcg tttagttgtc ctctcggctt 120
ctgctggtat cactaatctg ctggtcgctt tagctgaagg actggaacct ggcgagcgat 180
tcgaaaaact cgacgctatc cgcaacatcc agtttgccat tctggaacgt ctgcgttacc 240
cgaacgttat ccgtgaagag attgaacgtc tgctggagaa cattactgtt ctggcagaag 300
cggcggcgct ggcaacgtct ccggcgctga cagatgagct ggtcagccac ggcgagctga 360
tgtcgaccct gctgtttgtt gagatcctgc gcgaacgcga tgttcaggca cagtggtttg 420
atgtacgtaa agtgatgcgt accaacgacc gatttggtcg tgcagagcca gatatagccg 480
cgctggcgga actggccgcg ctgcagctgc tcccacgtct caatgaaggc ttagtgatca 540
cccagggatt tatcggtagc gaaaataaag gtcgtacaac gacgcttggc cgtggaggca 600
gcgattatac ggcagccttg ctggcggagg ctttacacgc atctcgtgtt gatatctgga 660
ccgacgtccc gggcatctac accaccgatc cacgcgtagt ttccgcagca aaacgcattg 720
atgaaatcgc gtttgccgaa gcggcagaga tggcaacttt tggtgcaaaa gtactgcatc 780
cggcaacgtt gctacccgca gtacgcagcg atatcccggt ctttgtcggc tccagcaaag 840
acccacgcgc aggtggtacg ctgatgtgca ataaaactga aaatccgccg ctgttccgcg 900
ctctggcgct tcgtcgcaat cagactctgc tcactttgca cagcctgaat atactgcatt 960
ctcgcgattt cctcgcggaa gttttcggca tcctcgcgcg gcataatatt tcggtagact 1020
taatcaccac gtcagaagtg agcgtggcat taacccttga taccaccggt tcaacctcca 1080
ctggcgatac gttgctgacg caatctctgc tgatggagct ttccgcactg tgtcgggtgg 1140
aggtggaaga aggtctggcg ctggtcgcgt tgattggcaa tgacctgcca aaagcctgcg 1200
gcgttggcaa agaggtattc ggcgtactgg aaccgttcaa cattcgcatg atttgttatg 1260
gcgcatccag ccataacctg tgcttcctgg tgcccggcga agatgccgag caggtggtgc 1320
aaaaactgca tagtaatttg tttgagtaa 1349
<210> 21
<211> 350
<212> PRT
<213> Escherichia coli
<400> 21
Met Lys Asn Val Gly Phe Ile Gly Trp Arg Gly Met Val Gly Ser Val
1 5 10 15
Leu Met Gln Arg Met Val Glu Glu Arg Asp Phe Asp Ala Ile Arg Pro
20 25 30
Val Phe Phe Ser Thr Ser Gln Leu Gly Gln Ala Ala Pro Ser Phe Gly
35 40 45
Gly Thr Thr Gly Thr Leu Gln Asp Ala Phe Asp Leu Glu Ala Leu Lys
50 55 60
Ala Leu Asp Ile Ile Val Thr Cys Gln Gly Gly Asp Tyr Thr Asn Glu
65 70 75 80
Ile Tyr Pro Lys Leu Arg Glu Ser Gly Trp Gln Gly Tyr Trp Ile Asp
85 90 95
Ala Ala Ser Ser Leu Arg Met Lys Asp Asp Ala Ile Ile Ile Leu Asp
100 105 110
Pro Val Asn Gln Asp Val Ile Thr Asp Gly Leu Asn Asn Gly Ile Arg
115 120 125
Thr Phe Val Gly Gly Asn Cys Thr Val Ser Leu Met Leu Met Ser Leu
130 135 140
Gly Gly Leu Phe Ala Asn Asp Leu Val Asp Trp Val Ser Val Ala Thr
145 150 155 160
Tyr Gln Ala Ala Ser Gly Gly Gly Ala Arg His Met Arg Glu Leu Leu
165 170 175
Thr Gln Met Gly His Leu Tyr Gly His Val Ala Asp Glu Leu Ala Thr
180 185 190
Pro Ser Ser Ala Ile Leu Asp Ile Glu Arg Lys Val Thr Thr Leu Thr
195 200 205
Arg Ser Gly Glu Leu Pro Val Asp Asn Phe Gly Val Pro Leu Ala Gly
210 215 220
Ser Leu Ile Pro Trp Ile Asp Lys Gln Leu Asp Asn Gly Gln Ser Arg
225 230 235 240
Glu Glu Trp Lys Gly Gln Ala Glu Thr Asn Lys Ile Leu Asn Thr Ser
245 250 255
Ser Val Ile Pro Val Asp Gly Leu Cys Val Arg Val Gly Ala Leu Arg
260 265 270
Cys His Ser Gln Ala Phe Thr Ile Lys Leu Lys Lys Asp Val Ser Ile
275 280 285
Pro Thr Val Glu Glu Leu Leu Ala Ala His Asn Pro Trp Ala Lys Val
290 295 300
Val Pro Asn Asp Arg Glu Ile Thr Met Arg Glu Leu Thr Pro Ala Ala
305 310 315 320
Val Thr Gly Thr Leu Thr Thr Pro Val Gly Arg Leu Arg Lys Leu Asn
325 330 335
Met Gly Pro Glu Phe Leu Ser Ala Phe Thr Val Gly Asp Gln
340 345 350
<210> 22
<211> 1104
<212> DNA
<213> Escherichia coli
<400> 22
atgaaaaatg ttggttttat cggctggcgc ggtatggtcg gctccgttct catgcaacgc 60
atggttgaag agcgcgactt cgacgccatt cgccctgtct tcttttctac ttctcagctt 120
ggccaggctg cgccgtcttt tggcggaacc actggcacac ttcaggatgc ctttgatctg 180
gaggcgctaa aggccctcga tatcattgtg acctgtcagg gcggcgatta taccaacgaa 240
atctatccaa agcttcgtga aagcggatgg caaggttact ggattgacgc agcatcgtct 300
ctgcgcatga aagatgacgc catcatcatt cttgaccccg tcaatcagga cgtcattacc 360
gacggattaa ataatggcat caggactttt gttggcggta actgtaccgt aagcctgatg 420
ttgatgtcgt tgggtggttt attcgccaat gatcttgttg attgggtgtc cgttgcaacc 480
taccaggccg cttccggcgg tggtgcgcga catatgcgtg agttattaac ccagatgggc 540
catctgtatg gccatgtggc agatgaactc gcgaccccgt cctctgctat tctcgatatc 600
gaacgcaaag tcacaacctt aacccgtagc ggtgagctgc cggtggataa ctttggcgtg 660
ccgctggcgg gtagcctgat tccgtggatc gacaaacagc tcgataacgg tcagagccgc 720
gaagagtgga aagggcaggc ggaaaccaac aagatcctca acacatcttc cgtaattccg 780
gtagatggtt tatgtgtgcg tgtcggggca ttgcgctgcc acagccaggc attcactatt 840
aaattgaaaa aagatgtgtc tattccgacc gtggaagaac tgctggctgc gcacaatccg 900
tgggcgaaag tcgttccgaa cgatcgggaa atcactatgc gtgagctaac cccagctgcc 960
gttaccggca cgctgaccac gccggtaggc cgcctgcgta agctgaatat gggaccagag 1020
ttcctgtcag cctttaccgt gggcgaccag ctgctgtggg gggccgcgga gccgctgcgt 1080
cggatgcttc gtcaactggc gtaa 1104
<210> 23
<211> 273
<212> PRT
<213> Escherichia coli
<400> 23
Met His Asp Ala Asn Ile Arg Val Ala Ile Ala Gly Ala Gly Gly Arg
1 5 10 15
Met Gly Arg Gln Leu Ile Gln Ala Ala Leu Ala Leu Glu Gly Val Gln
20 25 30
Leu Gly Ala Ala Leu Glu Arg Glu Gly Ser Ser Leu Leu Gly Ser Asp
35 40 45
Ala Gly Glu Leu Ala Gly Ala Gly Lys Thr Gly Val Thr Val Gln Ser
50 55 60
Ser Leu Asp Ala Val Lys Asp Asp Phe Asp Val Phe Ile Asp Phe Thr
65 70 75 80
Arg Pro Glu Gly Thr Leu Asn His Leu Ala Phe Cys Arg Gln His Gly
85 90 95
Lys Gly Met Val Ile Gly Thr Thr Gly Phe Asp Glu Ala Gly Lys Gln
100 105 110
Ala Ile Arg Asp Ala Ala Ala Asp Ile Ala Ile Val Phe Ala Ala Asn
115 120 125
Phe Ser Val Gly Val Asn Val Met Leu Lys Leu Leu Glu Lys Ala Ala
130 135 140
Lys Val Met Gly Asp Tyr Thr Asp Ile Glu Ile Ile Glu Ala His His
145 150 155 160
Arg His Lys Val Asp Ala Pro Ser Gly Thr Ala Leu Ala Met Gly Glu
165 170 175
Ala Ile Ala His Ala Leu Asp Lys Asp Leu Lys Asp Cys Ala Val Tyr
180 185 190
Ser Arg Glu Gly His Thr Gly Glu Arg Val Pro Gly Thr Ile Gly Phe
195 200 205
Ala Thr Val Arg Ala Gly Asp Ile Val Gly Glu His Thr Ala Met Phe
210 215 220
Ala Asp Ile Gly Glu Arg Leu Glu Ile Thr His Lys Ala Ser Ser Arg
225 230 235 240
Met Thr Phe Ala Asn Gly Ala Val Arg Ser Ala Leu Trp Leu Ser Gly
245 250 255
Lys Glu Ser Gly Leu Phe Asp Met Arg Asp Val Leu Asp Leu Asn Asn
260 265 270
Leu
<210> 24
<211> 822
<212> DNA
<213> Escherichia coli
<400> 24
atgcatgatg caaacatccg cgttgccatc gcgggagccg gggggcgtat gggccgccag 60
ttgattcagg cggcgctggc attagagggc gtgcagttgg gcgctgcgct ggagcgtgaa 120
ggatcttctt tactgggcag cgacgccggt gagctggccg gagccgggaa aacaggcgtt 180
accgtgcaaa gcagcctcga tgcggtaaaa gatgattttg atgtgtttat cgattttacc 240
cgtccggaag gtacgctgaa ccatctcgct ttttgtcgcc agcatggcaa agggatggtg 300
atcggcacta cggggtttga cgaagccggt aaacaagcaa ttcgtgacgc cgctgccgat 360
attgcgattg tctttgctgc caattttagc gttggcgtta acgtcatgct taagctgctg 420
gagaaagcag ccaaagtgat gggtgactac accgatatcg aaattattga agcacatcat 480
agacataaag ttgatgcgcc gtcaggcacc gcactggcaa tgggagaggc gatcgcccac 540
gcccttgata aagatctgaa agattgcgcg gtctacagtc gtgaaggcca caccggtgaa 600
cgtgtgcctg gcaccattgg ttttgccacc gtgcgtgcag gtgacatcgt tggtgaacat 660
accgcgatgt ttgccgatat tggcgagcgt ctggagatca cccataaggc gtccagccgt 720
atgacatttg ctaacggcgc ggtaagatcg gctttgtggt tgagtggtaa ggaaagcggt 780
ctttttgata tgcgagatgt acttgatctc aataatttgt aa 822
<210> 25
<211> 396
<212> PRT
<213> Escherichia coli
<400> 25
Met Phe Glu Asn Ile Thr Ala Ala Pro Ala Asp Pro Ile Leu Gly Leu
1 5 10 15
Ala Asp Leu Phe Arg Ala Asp Glu Arg Pro Gly Lys Ile Asn Leu Gly
20 25 30
Ile Gly Val Tyr Lys Asp Glu Thr Gly Lys Thr Pro Val Leu Thr Ser
35 40 45
Val Lys Lys Ala Glu Gln Tyr Leu Leu Glu Asn Glu Thr Thr Lys Asn
50 55 60
Tyr Leu Gly Ile Asp Gly Ile Pro Glu Phe Gly Arg Cys Thr Gln Glu
65 70 75 80
Leu Leu Phe Gly Lys Gly Ser Ala Leu Ile Asn Asp Lys Arg Ala Arg
85 90 95
Thr Ala Gln Thr Pro Gly Gly Thr Gly Ala Leu Arg Val Ala Ala Asp
100 105 110
Phe Leu Ala Lys Asn Thr Ser Val Lys Arg Val Trp Val Ser Asn Pro
115 120 125
Ser Trp Pro Asn His Lys Ser Val Phe Asn Ser Ala Gly Leu Glu Val
130 135 140
Arg Glu Tyr Ala Tyr Tyr Asp Ala Glu Asn His Thr Leu Asp Phe Asp
145 150 155 160
Ala Leu Ile Asn Ser Leu Asn Glu Ala Gln Ala Gly Asp Val Val Leu
165 170 175
Phe His Gly Cys Cys His Asn Pro Thr Gly Ile Asp Pro Thr Leu Glu
180 185 190
Gln Trp Gln Thr Leu Ala Gln Leu Ser Val Glu Lys Gly Trp Leu Pro
195 200 205
Leu Phe Asp Phe Ala Tyr Gln Gly Phe Ala Arg Gly Leu Glu Glu Asp
210 215 220
Ala Glu Gly Leu Arg Ala Phe Ala Ala Met His Lys Glu Leu Ile Val
225 230 235 240
Ala Ser Ser Tyr Ser Lys Asn Phe Gly Leu Tyr Asn Glu Arg Val Gly
245 250 255
Ala Cys Thr Leu Val Ala Ala Asp Ser Glu Thr Val Asp Arg Ala Phe
260 265 270
Ser Gln Met Lys Ala Ala Ile Arg Ala Asn Tyr Ser Asn Pro Pro Ala
275 280 285
His Gly Ala Ser Val Val Ala Thr Ile Leu Ser Asn Asp Ala Leu Arg
290 295 300
Ala Ile Trp Glu Gln Glu Leu Thr Asp Met Arg Gln Arg Ile Gln Arg
305 310 315 320
Met Arg Gln Leu Phe Val Asn Thr Leu Gln Glu Lys Gly Ala Asn Arg
325 330 335
Asp Phe Ser Phe Ile Ile Lys Gln Asn Gly Met Phe Ser Phe Ser Gly
340 345 350
Leu Thr Lys Glu Gln Val Leu Arg Leu Arg Glu Glu Phe Gly Val Tyr
355 360 365
Ala Val Ala Ser Gly Arg Val Asn Val Ala Gly Met Thr Pro Asp Asn
370 375 380
Met Ala Pro Leu Cys Glu Ala Ile Val Ala Val Leu
385 390 395
<210> 26
<211> 1191
<212> DNA
<213> Escherichia coli
<400> 26
atgtttgaga acattaccgc cgctcctgcc gacccgattc tgggcctggc cgatctgttt 60
cgtgccgatg aacgtcccgg caaaattaac ctcgggattg gtgtctataa agatgagacg 120
ggcaaaaccc cggtactgac cagcgtgaaa aaggctgaac agtatctgct cgaaaatgaa 180
accaccaaaa attacctcgg cattgacggc atccctgaat ttggtcgctg cactcaggaa 240
ctgctgtttg gtaaaggtag cgccctgatc aatgacaaac gtgctcgcac ggcacagact 300
ccggggggca ctggcgcact acgcgtggct gccgatttcc tggcaaaaaa taccagcgtt 360
aagcgtgtgt gggtgagcaa cccaagctgg ccgaaccata agagcgtctt taactctgca 420
ggtctggaag ttcgtgaata cgcttattat gatgcggaaa atcacactct tgacttcgat 480
gcactgatta acagcctgaa tgaagctcag gctggcgacg tagtgctgtt ccatggctgc 540
tgccataacc caaccggtat cgaccctacg ctggaacaat ggcaaacact ggcacaactc 600
tccgttgaga aaggctggtt accgctgttt gacttcgctt accagggttt tgcccgtggt 660
ctggaagaag atgctgaagg actgcgcgct ttcgcggcta tgcataaaga gctgattgtt 720
gccagttcct actctaaaaa ctttggcctg tacaacgagc gtgttggcgc ttgtactctg 780
gttgctgccg acagtgaaac cgttgatcgc gcattcagcc aaatgaaagc ggcgattcgc 840
gctaactact ctaacccacc agcacacggc gcttctgttg ttgccaccat cctgagcaac 900
gatgcgttac gtgcgatttg ggaacaagag ctgactgata tgcgccagcg tattcagcgt 960
atgcgtcagt tgttcgtcaa tacgctgcag gaaaaaggcg caaaccgcga cttcagcttt 1020
atcatcaaac agaacggcat gttctccttc agtggcctga caaaagaaca agtgctgcgt 1080
ctgcgcgaag agtttggcgt atatgcggtt gcttctggtc gcgtaaatgt ggccgggatg 1140
acaccagata acatggctcc gctgtgcgaa gcgattgtgg cagtgctgta a 1191
<210> 27
<211> 30
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-SacI-F
<400> 27
tccgagctca tgaacgttat tgcaatattg 30
<210> 28
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-XbaI-R
<400> 28
gcctctagac cacttccctt gtacgagc 28
<210> 29
<211> 44
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-F2
<400> 29
atttcacaca ggaaacagct atgaacgtta ttgcaatatt gaat 44
<210> 30
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-R2
<400> 30
agctgtttcc tgtgtgaaat 20
<210> 31
<211> 59
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-RBS-F
<220>
<221> misc_feature
<222> (15)..(24)
<223> n is a, c, g, or t
<400> 31
cggataacaa tttcnnnnnn nnnncagcta tgaacgttat tgcaatattg aatcacatg 59
<210> 32
<211> 32
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer cadA-RBS-R
<400> 32
gaaattgtta tccgctcaca attccacaca ac 32
<210> 33
<211> 66
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer psyn-1
<400> 33
ggcgaattca gtttattctt gacatgtagt gagggggctg gtataatgag ctcggtaccc 60
ggggat 66
<210> 34
<211> 34
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer psyn-2
<400> 34
ggcagtactc aaccaagtca ttctgagaat agtg 34
<210> 35
<211> 49
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer tetA-F
<400> 35
ggcgagctca cacaggaaac agaccatgaa atctaacaat gcgctcatc 49
<210> 36
<211> 29
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer tetA-R
<400> 36
ggctctagat caacgacagg agcacgatc 29
<210> 37
<211> 46
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer lysC-F
<400> 37
ggcgagctca cacaggaaac agaccatgtc tgaaattgtt gtctcc 46
<210> 38
<211> 33
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer lysC-R
<400> 38
ggcggatcct tactcaaaca aattactatg cag 33
<210> 39
<211> 46
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer dapA-F
<400> 39
ggcggatcca cacaggaaac agaccatgtt cacgggaagt attgtc 46
<210> 40
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer dapA-R
<400> 40
ggctctagat tacagcaaac cggcatgc 28
<210> 41
<211> 46
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer lysA-F
<400> 41
ggctctagaa cacaggaaac agaccatgcc acattcactg ttcagc 46
<210> 42
<211> 30
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer lysA-R
<400> 42
ggcgtcgact taaagcaatt ccagcgccag 30
<210> 43
<211> 34
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer tetA-F3
<400> 43
ggcctcgaga gtttattctt gacatgtagt gagg 34
<210> 44
<211> 29
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer tetA-R3
<400> 44
ggcgcatgct caacgacagg agcacgatc 29
<210> 45
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer 318-F
<400> 45
cagcctgaat atactgcatt ctc 23
<210> 46
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer 318-R
<400> 46
gagaatgcag tatattcagg ctg 23
<210> 47
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer 323-F
<400> 47
gcattctcgc gatttcctcg 20
<210> 48
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer 323-R
<400> 48
cgaggaaatc gcgagaatgc 20
<210> 49
<211> 48
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer asd-F
<400> 49
ggcgagctca cacaggaaac agaccatgaa aaatgttggt tttatcgg 48
<210> 50
<211> 28
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer asd-R
<400> 50
ggcggatcct tacgccagtt gacgaagc 28
<210> 51
<211> 45
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer dapB-F
<400> 51
ggcggatcca cacaggaaac agaccatgca tgatgcaaac atccg 45
<210> 52
<211> 38
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer dapB-R
<400> 52
ggctctagat tacaaattat tgagatcaag tacatctc 38
<210> 53
<211> 46
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer aspC-F
<400> 53
ggctctagaa cacaggaaac agaccatgtt tgagaacatt accgcc 46
<210> 54
<211> 47
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer aspC-R
<400> 54
ggcgcatgcg acctcgaggt agtcgactta cagcactgcc acaatcg 47
<210> 55
<211> 34
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer LAL-F
<400> 55
ggcggtacca gtttattctt gacatgtagt gagg 34
<210> 56
<211> 29
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer LAL-R
<400> 56
ggcgggccct taaagcaatt ccagcgcca 29

Claims (12)

1. a kind of ribosome bind site, which is characterized in that the sequence 5 ' -3 ' of the ribosome bind site include/is as follows Shown in one of sequence:
a)、GTCATCAAAA;
b)、CGCAAAGATA;
c)、AAAGATTTAC。
2. a kind of recombinant expression plasmid, including the target gene of recombinant expression plasmid and corresponding ribosome bind site, special Sign is that the ribosome bind site is as described in any technical solution of claim 1, it is preferable that the ribosome binding site Point is located at upstream from start codon -15 and arrives -6.
3. a kind of recombinant expression plasmid as claimed in claim 2, which is characterized in that the skeleton plasmid of the recombinant expression plasmid It is one kind in pUC, pBR322, pACYC plasmid and their plasmid.
4. such as a kind of recombinant expression plasmid of claim 2-3 any one of them, which is characterized in that the recombinant expression plasmid Target gene is the polynucleotide for encoding polypeptide;The polypeptide is enzyme or polypeptide drug;It is further preferred that the enzyme It is at least one of oxidoreducing enzyme, transferase, hydrolase, lyase, isomerase and ligase, the polypeptide drug is At least one of hormone, antibody and growth factor;Further preferably, the lyase is decarboxylase, further excellent Selection of land, the decarboxylase are amino acid decarboxylases, such as lysine decarboxylase, tyrosine decarboxylase, arginine decarboxylase, ornithine Decarboxylase or glutamate decarboxylase.
5. a kind of recombinant expression plasmid according to claim 4, which is characterized in that the recombinant expression plasmid of the transformant Target gene be encode lysine decarboxylase polynucleotide;Preferably, the polynucleotide of the coding lysine decarboxylase It is derived from Escherichia coli (Escherichia coli), bacillus subtilis (Bacillus subtilis), basophilic gemma bar Bacterium (Bacillus halodurans), streptomyces coelicolor (Streptomyces coelicolor), hafnia alvei (Hafnia alvei), corynebacterium glutamicum (Corynebacterium glutamicum) or klebsiella oxytoca The lysine decarboxylase gene of (Klebsiella oxytoca);It is further preferred that the poly-nuclear glycosides of coding lysine decarboxylase Acid is the piece of cadA genes, ldcC genes, haldc genes, the segment of cadA genes, the segment of ldcC genes or haldc genes Section;It is further preferred that the cadA genes are derived from the cadA genes of Escherichia coli (E.coli).
6. a kind of transformant, which is characterized in that the genome of the transformant includes that target gene and corresponding ribosomes combine Site, the ribosome bind site are as described in claim 1, it is preferable that the ribosome bind site is located at initiation codon Sub- upstream -15 arrives -6;The target gene is the polynucleotide for encoding polypeptide;The polypeptide is enzyme or polypeptide drug; It is further preferred that the enzyme be in oxidoreducing enzyme, transferase, hydrolase, lyase, isomerase and ligase at least One kind, the polypeptide drug are at least one of hormone, antibody and growth factor;Further preferably, described to split conjunction Enzyme is decarboxylase, it is further preferred that the decarboxylase is amino acid decarboxylases, such as lysine decarboxylase, tyrosine decarboxylation Enzyme, arginine decarboxylase, ornithine decarboxylase or glutamate decarboxylase;
Alternatively, the recombinant expression plasmid of the transformant is such as claim 2-5 any one of them recombinant expression plasmids.
7. transformant as claimed in claim 6, which is characterized in that the recombinant expression plasmid of the transformant is such as claim Recombinant expression plasmid described in any one of 5 technical solutions.
8. the host strain of transformant as claimed in claims 6 or 7, the transformant is Escherichia coli (E.coli), withered grass bud Spore bacillus (B.subtilis), streptomyces coelicolor (S.coelicolor), hafnia alvei (H.alvei) or glutamic acid rod Shape bacillus (C.glutamicum) is further preferred that Escherichia coli (E.coli) or hafnia alvei (H.alvei).
9. a kind of method of fermenting and producing polypeptide, which is characterized in that include the following steps:
A claim 6-8 any one of them transformants) are cultivated;
B) polypeptide is obtained from the bacterium solution or thalline obtained in step A.
10. a kind of method of fermenting and producing polypeptide as claimed in claim 9, which is characterized in that be that fermenting and producing lysine is de- The method of carboxylic acid, includes the following steps:
1) culture such as claim 7-8 any one of them transformants;
2) lysine decarboxylase is obtained in the bacterium solution or thalline that are obtained from step 1.
11. a kind of fermenting and producing 1, the method for 5- pentanediamines, which is characterized in that include the following steps:
Culture such as claim 7-8 any one of them transformants, the host strain of the transformant can produce lysine, described to rely Propylhomoserin decarboxylation enzymatic lysine decarboxylation generates 1,5- pentanediamines.
12. a kind of mRNA, which is characterized in that the sequence of the mRNA includes and ribosome bind site described in claim 1 Corresponding sequence.
CN201710091152.0A 2017-02-20 2017-02-20 Ribosome binding site, recombinant expression plasmid, transformant and application thereof Active CN108456668B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710091152.0A CN108456668B (en) 2017-02-20 2017-02-20 Ribosome binding site, recombinant expression plasmid, transformant and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710091152.0A CN108456668B (en) 2017-02-20 2017-02-20 Ribosome binding site, recombinant expression plasmid, transformant and application thereof

Publications (2)

Publication Number Publication Date
CN108456668A true CN108456668A (en) 2018-08-28
CN108456668B CN108456668B (en) 2023-08-08

Family

ID=63228834

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710091152.0A Active CN108456668B (en) 2017-02-20 2017-02-20 Ribosome binding site, recombinant expression plasmid, transformant and application thereof

Country Status (1)

Country Link
CN (1) CN108456668B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113528561A (en) * 2020-04-14 2021-10-22 中国石油化学工业开发股份有限公司 Recombinant microorganism and method for producing 1, 5-pentanediamine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345838A (en) * 2000-09-29 2002-04-24 上海博德基因开发有限公司 Novel polypeptide-human protein 9.68 containing ribosomal protein S24e characteristic sequence fragment and polynucleotide for encoding said polypeptide
US20200299738A1 (en) * 2019-03-08 2020-09-24 Massachusetts Institute Of Technology Human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345838A (en) * 2000-09-29 2002-04-24 上海博德基因开发有限公司 Novel polypeptide-human protein 9.68 containing ribosomal protein S24e characteristic sequence fragment and polynucleotide for encoding said polypeptide
US20200299738A1 (en) * 2019-03-08 2020-09-24 Massachusetts Institute Of Technology Human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EUN YOUNG HONG ET AL.: "Simultaneously Enhancing the Stability and Catalytic Activity of Multimeric Lysine Decarboxylase CadA by Engineering Interface Regions for Enzymatic Production of Cadaverine at High Concentration of Lysine", 《BIOTECHNOLOGY JOURNAL》 *
朱婧: "微生物转化L-赖氨酸为尸胺的研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *
李乃强: "赖氨酸脱羧酶高效表达、分子定向进化及其催化合成戊二胺的反应过程特性", 《中国博士学位论文全文数据库基础科学辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113528561A (en) * 2020-04-14 2021-10-22 中国石油化学工业开发股份有限公司 Recombinant microorganism and method for producing 1, 5-pentanediamine
CN113528561B (en) * 2020-04-14 2024-03-01 台湾中国石油化学工业开发股份有限公司 Recombinant microorganism and method for producing 1, 5-pentanediamine

Also Published As

Publication number Publication date
CN108456668B (en) 2023-08-08

Similar Documents

Publication Publication Date Title
JP5486029B2 (en) Increased lysine production by gene amplification
CN106754850B (en) The glutamic acid decarboxylase enzyme mutant and its application that thermal stability improves
EP3162889A1 (en) Engineered escherichia coli for producing 1,5-pentanediamine by whole-cell catalysis and application thereof
CN108795912B (en) Lysine decarboxylase mutant and application thereof
CN106566823B (en) Cloning and application of glutamate decarboxylase gene
CN114752589B (en) Glutamic acid decarboxylase mutant and application thereof in production of gamma-aminobutyric acid
CN107208083A (en) Novel lysine decarboxylase and the method that cadaverine is prepared using it
CN108220288A (en) A kind of polynucleotide, transformant and its application
CN110291101A (en) The lysine decarboxylase of modification
CN114525268B (en) Glutamate decarboxylase mutant with improved pH tolerance and application of glutamate decarboxylase mutant in synthesis of gamma-aminobutyric acid
CN111286520B (en) Recombinant DNA for fermentation production of L-lysine, strain and application thereof
CN111411092A (en) Corynebacterium glutamicum with high L-lysine yield and application thereof
US10480003B2 (en) Constructs and systems and methods for engineering a CO2 fixing photorespiratory by-pass pathway
CN108456668A (en) A kind of ribosome bind site, recombinant expression plasmid, transformant and its application
CN111770993A (en) Modulation of CSR System to produce lysine and lysine derived products
CN108456669A (en) A kind of ribosome bind site, recombinant expression plasmid, transformant and its application
CN110872595B (en) Acid-resistant expression cassette and application thereof in fermentation production of organic acid
CN111321141B (en) Stationary phase specific promoter and application thereof
CN111662903B (en) Logarithmic phase specific promoter and application thereof
CN115197954B (en) Recombinant DNA for fermentative production of 1, 5-pentanediamine, strain and use thereof
CN114606172B (en) Bacillus amyloliquefaciens engineering bacteria for improving heme yield and construction method thereof
CN114410628A (en) Acid-resistant expression cassette, application thereof and method for high-throughput screening of stress-resistant expression cassette for microbial fermentation
CN111518820B (en) Recombinant DNA for fermentation production of L-lysine, strain and application thereof
CN109136297B (en) Process for producing 1, 5-pentanediamine
CN110157750A (en) A kind of improvement lysine decarboxylase, production method and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 4 / F, building 5, No. 1690, Cailun Road, Shanghai Free Trade Zone

Applicant after: CATHAY R&D CENTER Co.,Ltd.

Applicant after: CATHAY INDUSTRIAL BIOTECH Ltd.

Address before: 200120 Shanghai Zhangjiang High Tech Park of Pudong New Area Cailun Road No. 5 No. 1690

Applicant before: CATHAY R&D CENTER Co.,Ltd.

Applicant before: CATHAY INDUSTRIAL BIOTECH Ltd.

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20191028

Address after: 4 / F, building 5, No. 1690, Cailun Road, Shanghai Free Trade Zone

Applicant after: CATHAY R&D CENTER Co.,Ltd.

Applicant after: CIBT USA

Address before: 201203 floor 4, building 5, No. 1690, Cailun Road, Shanghai pilot Free Trade Zone

Applicant before: CATHAY R&D CENTER Co.,Ltd.

Applicant before: CATHAY INDUSTRIAL BIOTECH Ltd.

GR01 Patent grant
GR01 Patent grant